fluorodeoxyglucose f18 has been researched along with Bone Cancer in 858 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.23) | 18.7374 |
| 1990's | 32 (3.73) | 18.2507 |
| 2000's | 267 (31.12) | 29.6817 |
| 2010's | 452 (52.68) | 24.3611 |
| 2020's | 105 (12.24) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, G; Murrell, DF | 1 |
| Bulloch, G; Chatterjee, R; Donnan, L; Guo, A; MacManus, M; Seth, I; Seth, N; Siu, AHY | 1 |
| Alavi, A; Baun, C; Duvnjak, S; Falch, K; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Naghavi-Behzad, M | 1 |
| Jiang, C; Peng, X; Ye, H; Zhang, Y; Zheng, K | 1 |
| Aparisi Gómez, MP; Bazzocchi, A; Fanti, S; Farina, A; Gasperini, C; Nanni, C | 1 |
| Batus, M; Blank, AT; Colman, MW; Gitelis, S; Kazmer, A; Lee, L | 2 |
| Tang, P; Tian, R; Yang, G; Zhang, Y | 1 |
| Hu, S; Long, T | 1 |
| Frank, BJH; Kocijan, R; Lomoschitz, F; Resch, H; Simon, S | 1 |
| Baudin, E; Chevalier, B; Deschamps, F; Djennaoui, M; Do Cao, C; Hadoux, J; Jannin, A; Lamartina, L; Leboulleux, S; Lion, G; Moutarde, C; Schlumberger, M; Vantyghem, MC | 1 |
| Allen, SD; Bhaludin, BN; Downey, K; Gagliardi, T; Johnston, SRD; Koh, DM; McGrath, SE; Messiou, C; Okines, AF; Parton, MM; Pope, R; Ring, AE; Sharma, B; Tunariu, N | 1 |
| Chen, S; Gong, W; He, L; Liu, W; Zhang, C | 1 |
| Bai, Y; Dong, A; Nian, S; Zhang, J | 1 |
| Dong, A; Zhao, B; Zuo, C | 1 |
| Bachmann, IM; Haslerud, TM; Helgeland, L; Karlsdottir, Å; Reikvam, H; Thunestvedt, LMØ | 1 |
| Baur-Melnyk, A; Dürr, HR; Erber, B; Fink, N; Goller, SS; Knösel, T; Ricke, J | 1 |
| Chen, J; He, Y; Li, C; Tian, Y; Wen, B | 1 |
| An, C; Li, X; Zhang, W | 1 |
| Binkovitz, LA; Broski, SM; Guo, RR; Huls, SJ | 1 |
| Chen, H; Kong, L; Meng, T; Pang, Y; Xu, W | 1 |
| Bredella, MA; Vicentini, JRT | 1 |
| Alçın, G; Arslan, E; Beyhan, E; Çermik, TF; Erol, Ö; Güzelbey, B | 1 |
| Chang, CC; Chi, YM; Liu, CT; Yen, WJ | 1 |
| Campone, M; Colombie, M; Ferrer, L; Fourcade, C; Guillerminet, C; Jezequel, P; Lacombe, M; Moreau, N; Normand, N; Rousseau, C; Rubeaux, M; Santini, G | 1 |
| Mendoza, H; Nosov, A; Pandit-Taskar, N | 1 |
| Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA | 1 |
| Kabukcuoglu, F; Sahin, C | 1 |
| Guo, H; Liu, S; Ma, S; Wang, L; Xu, S; Yao, S; Zhang, Z | 1 |
| Guo, YH; Yang, MF | 1 |
| Abikhzer, G; Bénard, F; Black, P; Burrell, S; Cossette, M; Eigl, BJ; Harsini, S; Krauze, A; Mar, C; Martin, M; Metser, U; Nichol, A; Romsa, J; Saad, F; Soucy, JP; Tardif, JC; Turcotte, E; Wilson, D; Zukotynski, K | 1 |
| Chen, DL; Coffey, D; Cowan, AJ; Green, DJ; Gulhane, A; Holmberg, LA; Kosydar, S; Kwok, M; Lee, SS; Libby, E; Tseng, YD | 1 |
| Fukui, Y; Hamamoto, Y; Isogai, T; Takahashi, M | 1 |
| Du, C; Shao, G; Tian, R; Wang, F; Xie, Q; Yang, Z; Yao, X; Yu, F; Yu, J; Zang, S; Zhang, C; Zhang, P | 1 |
| Groen, RJW; Raijmakers, PG; Regelink, JC; Zweegman, S; Zwezerijnen, GJC | 1 |
| Bahri, H; Bouhamama, A; Brahmi, M; Corradini, N; Delattre, O; Guinot, A; Isnardi, V; Lapouble, E; Marec-Bérard, P; Pierron, G; Surdez, D; Tabone-Eglinger, S; Villemeur, M | 1 |
| Liu, W; Ou, X; Yao, X | 1 |
| Huang, WS; Lan, WZ; Li, Y; Liang, J; Xu, JH | 1 |
| Baykal Koca, S; Çermik, TF; Ergül, N; Sevindir, İ; Tatar, G | 1 |
| Huang, Z; Liu, Y; Tang, W | 1 |
| Cao, C; Chen, S; Chen, X; Fang, Y; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
| Bai, Y; Dong, A; Lin, X; Xu, S; Yang, B | 1 |
| Abougabal, AM; El-Noueam, K; Ettaby, A; Fadel, S; Soliman, H | 1 |
| Dimitriou, F; Ensle, F; Huellner, MW; Maurer, A; Schaab, JA | 1 |
| Alpoim, T; Cristo Santos, J; Duarte, H; Henriques Abreu, M; Henriques Abreu, P; Próspero, I; Seoane Santos, M; Sousa, S | 1 |
| Askar, H; Bashank, N; Hussein, A; Mekawy, M | 1 |
| Kessler, L | 1 |
| Chen, J; Fu, Z; Li, Q; Liu, M; Zhang, X | 1 |
| Adler, S; Basuli, F; Beck, JA; Cherukuri, A; Choyke, PL; Huang, S; Jagoda, EM; LeBlanc, AK; Olkowski, C; Phelps, TE; Ren, L; Roy, J; Ton, A; White, ME; Wong, K; Zhang, X | 1 |
| Cheng, Y; Liu, YT; Shao, D | 1 |
| Ae, K; Ariga, A; Hayakawa, K; Kurosawa, N; Matsumoto, S; Minami, Y; Saito, M; Tanizawa, T; Terauchi, T; Yamashita, K | 1 |
| Hanazaki, K; Kitagawa, H; Kobayashi, M; Maeda, H; Namikawa, T; Satake, H; Seo, S; Sugimoto, T; Tamura, M; Yokota, K | 1 |
| Dehner, LP; Frederickson, N; Hagedorn, KN; Lucas, JT; Mallinger, P; Messinger, YH; Mize, WA; Nelson, AT; Schultz, KAP; Shulkin, BL; Towbin, AJ | 1 |
| Dong, A; Fu, X; Liu, M; Zhu, Y; Zuo, C | 1 |
| Bastidas Tamayo, JF; Bronte Viedma, A; García-Velloso, MJ; Lajusticia Andrés, H; Menendez-Sanchez, S | 1 |
| Rasheed, N; Razi, M | 1 |
| Drabkin, MJ; Kishore, SA; Sofocleous, CT | 1 |
| Asano, N; Hirozane, T; Matsumoto, M; Morioka, H; Nakamura, M; Nakayama, R; Nishimoto, K; Okita, H; Otani, S; Sasaki, A; Sekita, T | 1 |
| Ikeda, T; Iwamoto, S; Kadowaki, T; Kimura, M; Kobayashi, K; Minamizaki, T; Nagaoka, S; Nishikawa, E; Tada, M; Tajima, F; Yano, S | 1 |
| Dhatt, SS; Kumar, R; Mittal, BR; Parihar, AS; Singh, H; Sood, A | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Das, S; Iqbal, S; Kapoor, R; Yanamandra, U | 1 |
| Fan, YZ; Rao, MH; Xiong, YL; Yan, QB; Yuan, GB; Zheng, CX | 1 |
| Kirchner, J; Riedl, CC; Ulaner, GA | 1 |
| Lee, HT; Pryma, DA; Sebro, R | 1 |
| Byun, BH; Cho, WH; Kim, W; Kong, CB; Lim, I; Lim, SM; Sheen, H; Song, WS; Woo, SK | 1 |
| Su, M; Tian, R; Zhao, Y; Zhou, Y | 1 |
| Berckmans, M; Boyadzhiev, D; Collette, L; Jamar, F; Lecouvet, FE; Michoux, N; Pasoglou, V; Triqueneaux, P; Vekemans, MC | 1 |
| Carella, C; Ferrari, C; Naglieri, E; Nappi, AG; Niccoli Asabella, A; Rubini, G | 1 |
| Abu-Hijleh, HA; Abualruz, A; Aldahamsheh, OO; Thalib, L; Younis, MH | 1 |
| Issa, G; Khan, S; Mulligan, M | 1 |
| Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S | 1 |
| Lambert, R; Mitchell, DA; Mourad, SA; Plouznikoff, N; Turcotte, RE; Turpin, S | 1 |
| Aggarwal, A; Goel, S; Gupta, M; Iqbal, A; Rao, A; Singh, S | 1 |
| Gambhir, S; Mishra, V; Ora, M; Singh, V; Suraj, AK | 1 |
| Autore, F; Fresa, A; Innocenti, I; Laurenti, L; Paolini, A; Sica, S; Sora, F; Zini, G | 1 |
| Chen, EJ; Chew, MT; Chye, PC; Tan, TH | 1 |
| Ainouche, A; Durot, C; Hoeffel, C; Morland, D; Papathanassiou, D | 1 |
| Li, L; Li, T; Liu, G; Zhu, L | 1 |
| Artiko, VM; Beatovic, S; Grozdic Milojevic, I; Nikitovic, M; Paripovic, L; Saponjski, J; Saranovic, D; Sobic Saranovic, DP | 1 |
| Ahlawat, S; Cleary, MX; Fayad, LM | 1 |
| Fan, Q; Su, M; Sun, J; Tian, R | 1 |
| Dejust, S; Jallerat, P; Jouannaud, C; Morland, D; Soibinet-Oudot, P | 1 |
| El-Hennawy, G; El-Kholy, E; Elkinaai, N; Farid, N; Kamel, A; Moustafa, H; Omar, W; Zaki, I | 1 |
| Chen, B; Feng, H; Li, C; Wang, S; Xie, J; Zhang, Y | 1 |
| Das, CJ; Kumar, R; Kumar, S; Patel, C; Raju, S; Sahoo, R; Sharma, A | 1 |
| Abraham, T; Chou, A; Doshi, H; Geller, D; Hoang, B; Loeb, D; Love, C; Moadel, R; Parkar, F; Tal, AL; Yang, R; Ye, K | 1 |
| Bensch, F; Brouwers, AH; de Vries, EGE; Elias, SG; Glaudemans, AWJM; Iersel, MW; Kwee, TC; Maduro, JH; Oosting, SF; Schröder, CP; van Es, SC; Velleman, T | 1 |
| Chen, X; Huang, Y; Jiang, Y; Luo, R; Wang, F | 1 |
| Chen, H; Pang, Y; Zhao, L | 1 |
| Houdek, MT; Johnson, JD; Rainer, WG; Rose, PS | 1 |
| Can, C; Gündoğan, C; Kömek, H | 1 |
| Engur, CO; Erdil, TY; Filizoglu, N; Ones, T; Turkoz, HK | 1 |
| Bai, C; Cheng, Y; Guan, M; Jia, N; Xing, J; Ying, H | 1 |
| Campbell, KM; DuBois, SG; Grier, HE; Shulman, DS | 1 |
| Chen, X; Chen, ZK; Pan, B; Wang, SC | 1 |
| De Meulenaere, V; De Wever, O; Deblaere, K; Descamps, B; Vanhove, C | 1 |
| He, T; Sun, J; Tian, R; Wang, H; Zhang, W | 1 |
| Demirel, BB; Demirtaş Şenlik, S; Efetürk, H; Ergürhan İlhan, İ; Esen Akkaş, B; Fidan, AK; Öztürk, İ; Uçmak, G | 1 |
| Ahmad, U; Ahmad, W; Hassan, A | 1 |
| Bogoni, M; Cerci, JJ; Cornelis, FH; Kirov, AS; Nanni, C; SchÖder, H; Shyn, PB; Sofocleous, CT; Solomon, SB; Tabacchi, E | 1 |
| Boye, K; Cesari, M; Guren, T; Hompland, I; Lobmaier, I; Longhi, A; Lorenz, S; Løndalen, AM; Meza-Zepeda, LA; Næss, S; Paioli, A; Palmerini, E; Pierini, M; Setola, E; Sundby Hall, K; Taksdal, I | 1 |
| Agarwal, R; Gupta, N; Khare, A | 1 |
| Aryal, A; Gamanagatti, S; Khan, SA; Kumar, VS; Shamim, SA | 1 |
| Bar-Shalom, R; Ben Haim, S; Chicheportiche, A; Godefroy, J; Levy, A; Meital, AN; Rosenbach, E | 1 |
| Cao, Y; Hu, J; Li, J; Liu, J; Ma, W; Man, S; Yan, J; Zhao, Q | 1 |
| Adlerstein L, I; Barahona Z, D; Faure R, MI | 1 |
| Agrawal, A; Bal, M; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Suthar, RR | 1 |
| Harada, Y; Kawamura, R; Shimizu, T; Suzuki, Y | 1 |
| Arizono, S; Furuta, A; Isoda, H; Kataoka, TR; Kohno, S; Nakao, S; Tanabe, M; Togashi, K; Tokunaga, K | 1 |
| Benz, MR; Crompton, JG; Harder, D | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Su, IH; Tsai, KY | 1 |
| Gong, W; Liao, T; Liu, Y; Wu, J; Zhang, C | 1 |
| Broski, SM; Clark, MS; Glazebrook, KN; Howe, BM; Mauermann, ML | 1 |
| Kang, S; Park, I | 1 |
| Amorim, B; Brito, AE; Cabello, C; Etchebehere, E; Lima, M; Mosci, C; Oliveira, P; Ramos, CD; Santos, A; Sasse, AD; Souza, T | 1 |
| Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
| Costa, G; Lapa, P; Lima, JP; Marques, M; Saraiva, T; Silva, R | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Adams, HJA; de Klerk, JMH; Dubois, SV; Heggelman, BGF; Kwee, TC; Nix, M | 1 |
| Li, ZG; Mu, HY | 1 |
| Bahk, WJ; Chang, ED; Kang, YK; Lee, AH; Min, DW | 1 |
| Anderson, K; Attal, M; Avet-Loiseau, H; Benboubker, L; Bodet-Milin, C; Caillon, F; Caillot, D; Chaleteix, C; Dorvaux, V; Dupas, B; Escoffre-Barbe, M; Eveillard, JR; Facon, T; Frampas, E; Garderet, L; Gaultier, A; Hulin, C; Karlin, L; Kraeber-Bodere, F; Laribi, K; Macro, M; Marit, G; Moreau, P; Munshi, NC; Nguyen, JM; Pegourie, B; Perrot, A; Richardson, P; Stoppa, AM | 1 |
| Abouzied, ME; AlQahtani, M; Alsugair, A; Aras, O; Demirkaya, O | 1 |
| González, J; González, P; Hiplan, E; Humeres, P; Prado, E | 1 |
| Argon, AM; Avci, NC; Yararbas, U; Yeniay, L | 1 |
| He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X | 1 |
| Albano, D; Bertagna, F; Bosio, G; Giubbini, R; Treglia, G | 1 |
| Gomi, N; Hatake, K; Ito, Y; Koizumi, M; Koyama, M; Sata, N; Sugihara, T; Terauchi, T | 1 |
| Chen, H; Chen, Y; He, S; Hong, S; Liang, S; Peng, P; Wang, Y; Xia, L; Yang, L | 1 |
| Al-Muqbel, KM | 1 |
| Gelfand, MJ; McCarville, MB; Sharp, SE; Shulkin, BL | 1 |
| Ambinder, EB; Rowe, SP | 1 |
| de Clermont, H; Laffon, E; Marthan, R; Paycha, F | 1 |
| Boellaard, R; Glaudemans, AWJM; Jutte, PC; Kasalak, Ö; Kwee, TC; Overbosch, J | 1 |
| Glaudemans, AWJM; Jutte, PC; Kasalak, Ö; Kwee, TC; Overbosch, J | 1 |
| Donald, JS; Morgan, RL; Perry, MA; Peterson, JK | 1 |
| Bellò, M; Deandreis, D; Finessi, M; Giunta, FP; Veltri, A | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D | 1 |
| Fanti, S; Farolfi, A; Frisoni, T; Matti, A; Nanni, C | 1 |
| Basher, RK; Gorla, AKR; Kakkar, N; Mittal, BR; Sen, RK; Sood, A; Vadi, SK | 1 |
| An, YS; Jin Lee, S; Kang, SY; Park, S; Yim, H; Yoon, JK | 1 |
| Doubrovin, M; Federico, S; Hsu, CY; Hua, CH; Kaste, S; Krasin, M; Lucas, JT; Merchant, TE; Metzger, M; Mohammed, O; Shulkin, BL; Tinkle, C | 1 |
| Matsushima, S; Nishimura, M; Okuyama, C; Sasaki, N; Yoshimatsu, R | 1 |
| Lapa, P; Pedroso de Lima, J | 1 |
| Dirksen, U; Heinemann, M; Jürgens, H; Langer, T; Ranft, A; Stegger, L; Timmermann, B; Vieth, V; Weckesser, M | 1 |
| Dasgupta, A; Gaber, MW; Kurenbekova, L; Shapiro, MC; Shuck, R; Tang, T; Yustein, JT | 1 |
| Attinà, G; Giordano, A; Lanni, V; Librizzi, A; Mastrangelo, S; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
| Ammann, RA; Attarbaschi, A; Balwierz, W; Baumann, J; Beishuizen, A; Cepelova, M; Chavdarova, L; Daw, S; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Pears, J; Pelz, T; Sabri, O; Stoevesandt, D; Uyttebroeck, A; Wallace, WH | 1 |
| Kuo, DJ; Paul, MR | 1 |
| Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E | 1 |
| Dong, A; Ran, P; Wang, Y; Wu, S; Zhang, Y | 1 |
| Jebasingh, FK; Naik, D; Prabhu, K; Thomas, N | 1 |
| Gadi, VK; Gralow, J; Jenkins, I; Kinahan, P; Lee, JH; Linden, HM; Mankoff, D; Montgomery, S; Muzi, M; Novakova-Jiresova, A; O'Sullivan, J; Peterson, LM; Shields, A; Specht, JM; Wu, QV | 1 |
| Guan, Z; Zhang, X | 1 |
| Dong, C; Tan, Y; Wang, Y; Xiao, Z; Yang, X; Zhang, H | 1 |
| Agrawal, R; Asopa, RV; Malhotra, G; Meshram, V; Sonavane, S; Verma, P | 1 |
| Colletti, PM; Wassef, HR | 1 |
| Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S | 1 |
| Abe, K; Aiba, H; Hayashi, K; Higuchi, T; Igarashi, K; Ikeda, H; Inatani, H; Miwa, S; Mochizuki, T; Shirai, T; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N | 1 |
| Ambrosini, V; Ardizzoni, A; Comito, F; Melotti, B; Sperandi, F | 1 |
| Luo, QY; Qiu, ZL; Shen, CT; Sun, ZK | 1 |
| Bozkurt, M; Çayir, D; Gültekin, SS; Karaçalioğlu, AÖ | 1 |
| Byun, BH; Cho, WH; Kim, BI; Koh, JS; Kong, CB; Lee, I; Lim, I; Lim, SM; Song, WS | 1 |
| Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K | 1 |
| Asadoorian, M; Matcuk, GR; Patel, DB; Tomasian, A; Wassef, HR; White, EA | 1 |
| Gholamrezanezhad, A; Jadvar, H; Katal, S; Kessler, M; Olyaei, M | 1 |
| Basques, K; Behzadi, AH; Carrino, JA; Gholamrezanezhad, A; Jadvar, H; Kosmas, C; Matcuk, GR; Patel, J; Raza, SI | 1 |
| Kuang, A; Liu, B; Shen, G; Su, M | 1 |
| Bagetakos, I; Becker, M; Botsikas, D; Boudabbous, S; Da Cunha Afonso Barisits, AC; Kalovidouri, A; Lam, GT; Mainta, I; Montet, X; Picarra, M | 1 |
| Alessi, S; Bellomi, M; Colleoni, MA; Iorfida, M; Petralia, G; Pricolo, P; Ruju, F; Zugni, F | 1 |
| Lin, J; Sun, W; Tang, K; Wang, L | 1 |
| Tamam, C; Tamam, M | 1 |
| Bal, A; Bhattacharya, A; Kumar, R; Mittal, BR; Prakash, G; Singh, H; Singh, N | 1 |
| Al-Zaghal, A; Alavi, A; Raynor, WY; Seraj, SM; Zadeh, MZ | 1 |
| Choi, ES; Kang, HG; Kim, HS; Kim, JH; Kim, YI; Lin, PP | 1 |
| Cai, X; Dong, J; Huang, T; Li, F; Liu, F; Ma, Y; Xiong, F; Yan, Z; Zhang, Q | 1 |
| Gillis, E; Wen, Z; Zhuang, H | 1 |
| Chen, B; Guan, Q; Ji, B; Wang, R; Wang, X | 1 |
| Huang, D; Ou, X; Ye, Y; Zhang, W | 1 |
| Wang, LJ; Wang, QS; Wu, HB; Yu, SR; Zhou, WL | 1 |
| Mahindra, A; Pham, A | 1 |
| Jiao, Y; Luo, QY; Qiu, Z; Ren, X; Shen, C; Song, H; Wang, Q; Wei, W; Yang, Q | 1 |
| Fukushima, T; Gomi, D; Kobayashi, T; Koizumi, T; Oguchi, K; Sekiguchi, N | 1 |
| Bao, X; Lu, S; Niu, X; Wang, M; Wang, Q; Wang, S; Wang, Y; Xu, L; Zhang, J | 1 |
| Borzì, G; Frasca, F; Gullo, D; Ilenia, M; Malandrino, P; Russo, M | 1 |
| Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
| Koizumi, M; Motegi, K; Umeda, T | 1 |
| Kairemo, K; Subbiah, V; Wang, WL | 1 |
| Higashi, T; Ishizu, K; Kagawa, S; Kusano, K; Nakamoto, R; Okuyama, C; Takahashi, M; Yamauchi, H | 1 |
| Amini, RM; Andersen, MD; Barrington, SF; d'Amore, AL; d'Amore, F; Enblad, G; Gormsen, LC; Hamilton-Dutoit, S; Johnson, P; Kamper, P; Molin, D; Pedersen, MA; Wassberg, C | 1 |
| Beets-Tan, RGH; Donswijk, ML; Jóźwiak, K; Kusters, M; Lahaye, MJ; Lambregts, DMJ; Maas, M; Min, LA; Roberti, S; Vegt, E; Vogel, WV; Zijlmans, HJ | 1 |
| Albano, D; Bertagna, F; D'Ippolito, C; Dondi, F; Giubbini, R; Porta, F; Schumacher, RF | 1 |
| Anbai, A; Hashimoto, M; Hatakeyama, K; Kumagai, S; Okuyama, E; Takagi, N; Wada, Y | 1 |
| Bom, HS; Chowdhury, MSA; Jeon, S; Kwon, SY; Min, JJ | 1 |
| Charabi, B; Fischer, BM; Friborg, J; Gram, SB; Håkansson, K; Nøhr, A; Rasmussen, JH; Tvedskov, JF; von Buchwald, C; Wessel, I | 1 |
| Inaki, A; Kinuya, S; Mochizuki, T; Nakajima, K; Wakabayashi, H | 1 |
| Fujimoto, K; Hino, A; Inoue, T; Ishibashi, M; Kaida, H; Kurata, S; Shizukuishi, K; Tateishi, U; Yoneyama, T | 1 |
| Dick, DW; Gambhir, SS; Herfkens, R; Iagaru, A; Mittra, E; Young, P | 1 |
| Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O | 1 |
| Duo, J; Han, X; Ma, Y; Wang, G; Yang, Y; Zhang, L | 1 |
| Enoki, Y; Fujimoto, S; Fukui, A; Morishita, H; Okuyama, Y; Yoshida, N | 1 |
| Chang, CC; Chen, YW; Hou, MF; Huang, CJ; Lin, CY; Yang, WC | 1 |
| Bakhshi, S; Bal, C; Khan, SA; Khangembam, BC; Kumar, R; Malhotra, A; Rastogi, S; Sharma, P; Singh, H; Suman, KC; Thulkar, S | 1 |
| Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
| Correia, L; Leitão, T; Lopes, T; Martins, F; Palma Dos Reis, J; Pereira E Silva, R | 1 |
| Bishop, WD; Bonyadlou, S; Henderson, R; Kim, A; Sheth, S | 1 |
| Hwang, SJ; Lee, SH; Moon, SW; Park, CB; Sa, YJ; Sim, SB | 1 |
| Colling, CW; Robinson, RA; Vaena, DA; Wudhikarn, K | 1 |
| Angoue, O; Blagosklonov, O; Boulahdour, H; Caoduro, C; Singeorzan, CM; Ungureanu, CM | 1 |
| Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
| Alavi, A; Basu, S; Cheng, G; Kwee, TC | 1 |
| Casey, R; Maher, M; Moore, M; O'Halloran, D; Prendeville, S; Slattery, D | 1 |
| Ito, S; Iwano, S; Kawai, H; Naganawa, S; Ogawa, H; Sakurai, Y | 1 |
| Andreou, A; Fisher, C; MacVicar, D; Sohaib, A; Whitten, C | 1 |
| Hickeson, M; Holcroft, C; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Tulbah, R; Turcotte, R | 1 |
| Avery, R; Kuo, PH | 1 |
| Iwanaka, T; Kanamori, Y; Momose, T; Takahashi, M | 1 |
| Ametamey, SM; Arlt, MJ; Born, W; Brennecke, P; Campanile, C; Fischer, CR; Fuchs, B; Gvozdenovic, A; Honer, M; Krämer, SD; Müller, A; Sabile, AA; Schibli, R | 1 |
| Aparici, CM; Win, AZ | 1 |
| Jeon, TJ; Kim, JH; Lee, SI; Lee, YC; Ma, DW; Park, H; Youn, YH; Yun, M | 1 |
| Warner, RR; Zanzi, I | 1 |
| Cao, Q; Chen, W; Dilsizian, V; Huebner, T; Lu, M | 1 |
| Chen, YR; Hsieh, TC; Kao, CH; Shen, YY; Yen, KY | 1 |
| Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
| Hu, M; Huo, ZW; Li, MH; Liu, NB; Sun, XR; Xu, WG; Yu, JM; Zhu, L | 1 |
| Hama, Y | 1 |
| Adli, M; Alkis, H; Andic, F; Kuzhan, A; Yilmaz, M | 1 |
| Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Kim, BI; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 2 |
| Achmad, A; Arisaka, Y; Higuchi, T; Morita, M; Tokue, A; Tsushima, Y | 1 |
| Peller, PJ | 1 |
| de Lima, JM; Dick, DW; Gambhir, SS; Iagaru, A; Lapa, P; Mosci, C; Sathekge, M | 1 |
| Kang, HG; Kim, HS; Kim, JH; Kim, SK; Kim, YI | 1 |
| Azuma, Y; Kuwano, H; Okada, T; Sasamoto, H; Tajima, K; Uchida, N; Yokoo, H | 1 |
| Gao, Y; Li, M; Lu, H | 1 |
| Akaike, K; Kaneko, K; Okubo, T; Saito, T; Suehara, Y; Takagi, T; Torigoe, T; Yao, T | 1 |
| Arana Yi, C; Axelrod, R; Machtay, M; McCue, P; Morris, GJ; Rosen, M | 1 |
| Al-Muqbel, KM; Al-Omari, MH; Alqudah, MA; Audat, ZA | 1 |
| Ouvrier, MJ; Thariat, J; Vignot, S | 1 |
| Alvarez, M; Debard, A; Mandegaran, R; Marchou, B; Massip, P; Wagner, T | 1 |
| Fan, M; Liu, S; Liu, Y; Yi, X; Zhang, H | 1 |
| Abe, S; Fujita, N; Ito, S; Iwano, S; Kato, K; Naganawa, S; Ota, N; Yamamoto, S; Yamashiro, K | 1 |
| Beer, AJ; Eiber, M; Fürst, S; Gaertner, FC; Loeffelbein, DJ; Mayerhoefer, ME; Rummeny, EJ; Schwaiger, M; Souvatzoglou, M; Takei, T; Ziegler, SI | 1 |
| Chouiter, A; Lebowitz, D; Malinverni, R; Wolter, L; Zenklusen, C | 1 |
| Borbély, K; Géczi, L; Kásler, M | 1 |
| Brown, Pde N; Bukh, A; Bøgsted, M; d'Amore, F; El-Galaly, TC; Gormsen, LC; Hutchings, M; Iyer, V; Johnsen, HE; Kamper, P; Loft, A; Mylam, KJ; Nielsen, AL | 1 |
| Droeser, RA; Jundt, G; Kettelhack, C; Kirchhoff, P; Oertli, D; Rothschild, SI; Tornillo, L | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Almeida, GS; Bacon, CM; Batey, MA; Blair, H; Dildey, P; Heidenreich, O; Hide, IG; Knizia, HK; Maxwell, RJ; Sharma, A; Vormoor, B; Vormoor, J; Wilson, I | 1 |
| Beale, T; Bomanji, J; Dileo, P; Frezza, AM; Jay, A; Kalavrezos, N; Strauss, SJ; Whelan, J | 1 |
| Brown, JE; Fox, P; Mawlawi, O; Millican, R; Rahim, S; Rohren, EM; Swanston, NM; Taylor, S | 1 |
| Conrad, EU; Eary, JF; Hawkins, DS; O'Sullivan, F; O'Sullivan, J; Schuetze, SM | 1 |
| Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Rusca, T; Treglia, G | 1 |
| Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A | 1 |
| Cho, A; Choi, YJ; Hwang, HS; Jeong, YH; Kang, WJ; Kim, HJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Chang, JS; Choi, SH; Jeong, YH; Lee, Y; Seong, J; Yun, M | 1 |
| Cho, YS; Chung, DR; Kim, BT; Lee, EJ; Lee, KH | 1 |
| Bailly, M; Besse, H; Gauvain, S; Kerdraon, R; Metrard, G | 1 |
| Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A | 1 |
| Hu, C; Hu, S; Li, D; Pan, H; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Healey, JH; Magnan, H; Meyers, PA; Ulaner, GA; Weber, WA | 1 |
| Bonar, SF; Earwaker, J; Gragnaniello, C; Magnussen, J; Seex, K; Watson, G | 1 |
| Adib, S; Beauvais, D; Berthon, C; Bonnet, S; Coiteux, V; Decaux, O; Demarquette, H; Facon, T; Fouquet, G; Guidez, S; Herbaux, C; Hivert, B; Huglo, D; Leleu, X; Macro, M; Terriou, L; Van de Wyngaert, Z; Wemeau, M | 1 |
| Choi, YY; Kim, JY; Yang, SO | 1 |
| Gallivanone, F; Gastiglioni, I; Gilardi, MC; Messa, C; Stefano, A | 1 |
| Bie, P; Huan, H; Lau, WY; Li, G; Ma, K; Qian, C; Wu, L; Xia, F | 1 |
| Boerman, OC; Fleuren, ED; Flucke, UE; Franssen, GM; Houghton, PJ; Oyen, WJ; Roeffen, MH; van der Graaf, WT; Versleijen-Jonkers, YM | 1 |
| Asa, S; Halaç, M; Sager, S; Uslu, L | 1 |
| Chuang, HH; Costelloe, CM; Madewell, JE | 1 |
| Guo, FJ; Hao, Y; He, JP; Li, M; Wang, J | 1 |
| Canbaz Tosun, F; Cıraklı, A; Cıraklı, S; Dabak, N; Dağdemir, A; Elli, M | 1 |
| Baba, H; Baba, Y; Ida, S; Ishimoto, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Sakamoto, Y; Watanabe, M; Yamao, T | 1 |
| Hakozaki, M; Hasegawa, O; Konno, S; Tajino, T; Tasaki, K; Watanabe, K; Yamada, H | 1 |
| Beiderwellen, K; Grueneisen, J; Heusch, P; Huebner, M; Kuehl, H; Lauenstein, TC; Nensa, F; Rosenbaum-Krumme, S; Ruhlmann, V; Umutlu, L | 1 |
| Doran, MG; Fareedy, SB; Gavane, S; Osborne, JR; Spratt, DE; Tarlinton, L; Zelefsky, MJ | 1 |
| Ibe, T; Igai, H; Kamiyoshihara, M; Kawatani, N; Shimizu, K | 1 |
| Colletti, PM; Lisato, LC; Maffione, AM; Marzola, MC; Rasi, A; Rubello, D | 1 |
| Bal, C; Jain, TK; Karunanithi, S; Kumar, R; Singh, A | 1 |
| Aboagye, EO; Mann, D; Nguyen, QD; Patel, CB; Sala, R; Steinke, JH; Vilar, R | 1 |
| Borges, US; da Silva, BB; Gebrim, LH; Lopes-Costa, PV; Pires, AO | 1 |
| Chen, Y; Guan, Y; Li, J; Xia, T | 1 |
| Hino-Shishikura, A; Inoue, T; Kawahara, N; Tateishi, K; Tateishi, U; Torii, I | 1 |
| Fukui, T; Kawaguchi, K; Nishimura, M; Taniguchi, T; Yokoi, K | 1 |
| Liang, S; Ma, C; Wang, H; Zhang, L | 1 |
| Chagawa, K; Hirano, Y; Kido, S; Muramatsu, K; Suga, K; Tachibana, R; Tanaka, S; Xu, R | 1 |
| Jeraj, R; Liu, G; Perlman, S; Simoncic, U; Staab, MJ; Straus, JE | 1 |
| Patel, CN; Robinson, RJ; Tachibana, A | 1 |
| Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK | 1 |
| Bhatnagar, A; Fisher, PB; Gabrielson, K; Gabrielson, M; Green, G; Mease, RC; Minn, I; Pomper, MG; Sarkar, S; Simmons, B; Sysa, P; Wang, Y | 1 |
| Dammacco, F; Ferrari, C; Racanelli, V; Rubini, G; Vacca, A | 1 |
| Cappetta, A; Evangelista, L; Opocher, G; Pastorelli, D; Spano, L; Zovato, S | 1 |
| Colvin, OC; Escobar, E; Nguyen, BD | 1 |
| Kwok, RK; Lee, AC | 1 |
| Harish, K; Maka, V | 1 |
| Amini, B; Kubicki, SL; Martin, T; Richardson, ML; Rohren, E; Wei, W | 1 |
| Chen, Q; Chen, W; Dilsizian, V; Kim, J; Kimball, AS; Resnik, C | 1 |
| Weber, MA | 2 |
| Asuaje, ED; Buteau, JP; Keu, KV; Ochoa, CA; Rizcallah, E; Rousseau, É; Turcotte, É | 1 |
| Cha, RR; Jung, WT; Kim, HJ; Kim, NY; Kim, TH; Lee, JH; Lee, OJ; Oh, HW | 1 |
| O'Connor, W; Quintana, M; Renner, J; Smith, S; Willis, M | 1 |
| Chang, KJ; Cho, WH; Jeon, DG; Kong, CB; Lee, SY; Lim, I; Lim, SM | 1 |
| Choi, HJ; Kang, WJ; Kim, GM; Kim, JH; Seo, HJ | 1 |
| Bettinardi, V; De Bernardi, E; Gianolli, L; Gilardi, MC; Magnani, P | 1 |
| Chalian, M; Fergus, N; Kosmas, C; Mansoori, B; Partovi, S; Robbin, MR; Ros, PR; Zipp, L | 1 |
| Bredella, MA; Chang, CY; Gill, CM; Huang, AJ; Joseph Simeone, F; Taneja, AK; Torriani, M | 1 |
| Baldari, S; Cistaro, A; Fox, J; Kuk, D; Quartuccio, N; Schöder, H; Wexler, LH | 1 |
| de Waal, EG; Kluin, PM; Leene, MJ; Slart, RH; Vellenga, E | 1 |
| Ditt, H; Homann, G; Horger, M; Kopp, HG; Mustafa, DF; Nikolaou, K; Spengler, W | 1 |
| Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA | 1 |
| Koizumi, M; Koyama, M; Takahashi, S; Takeshima, N; Umayahara, K | 1 |
| Li, X; Liu, S; Wang, M; Yao, S | 1 |
| Aksu, R; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Tasdemir, B; Teke, F; Teke, M; Urakci, Z | 1 |
| Byun, BH; Cho, WH; Chung, SK; Jeon, DG; Kim, SH; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
| Boriani, S; Cappelli, A; Fanti, S; Gasbarrini, A; Golfieri, R; Graziani, T; Guidalotti, P; Nanni, C; Sandler, I | 1 |
| Apte, AP; Burger, IA; Carlin, SA; Deasy, JO; Dogan, S; Durack, JC; Erinjeri, JP; Fanchon, LM; Humm, JL; Kirov, AS; Maybody, M; Moreira, AL; Schmidtlein, CR; Schöder, H; Siegelbaum, RH; Sofocleous, CT; Solomon, SB; Yorke, E | 1 |
| Ding, G; Fu, Z; Huang, W; Kong, L; Li, M; Yang, G; Yu, J; Zhang, Y; Zhao, F | 1 |
| Chen, Y; Huang, Z; Qiu, L; Wen, Q; Zhu, Y | 1 |
| Aronen, HJ; Auren, J; Huovinen, R; Jambor, I; Kajander, S; Kauppila, E; Kemppainen, J; Kuisma, A; Merisaari, H; Minn, H; Noponen, T; Ramadan, S; Sandell, M; Saunavaara, J; Seppänen, M | 1 |
| Chan, HP; Hu, C; Huang, TC; Peng, NJ; Yu, CC | 1 |
| Catalano, M; Catalano, OA; Guimaraes, A; Iannace, C; Luongo, A; Mahmood, U; Nicolai, E; Rosen, BR; Salvatore, M; Soricelli, A; Vangel, MG | 1 |
| Chen, L; Cheng, L; Li, H; Wang, J; Xie, Q; Zhang, L; Zhang, Y | 1 |
| Cavalli, F; Ceriani, L; Griguolo, G; Mazzucchelli, L; Stathis, A; Zucca, E | 1 |
| Chatelus, E; Guffroy, A; Helali, M; Imperiale, A; Merle, B | 1 |
| Ishii, S; Kikuchi, K; Miyajima, M; Sakuma, K; Shishido, F | 1 |
| Inoue, T; Isahai, N; Momoi, A; Nagai, K; Sakai, T; Sekiya, M | 1 |
| Corben, AD; Dashevsky, BZ; Goldman, DA; Gönen, M; Hudis, CA; Jochelson, MS; Morrow, M; Parsons, M; Ulaner, GA | 1 |
| Berwouts, D; Bultijnck, R; De Lobel, L; De Neve, W; De Wolf, K; Goetghebeur, E; Goethals, I; Jans, L; Lambert, B; Madani, I; Olteanu, LA; Ost, P; Speleers, B | 1 |
| Imataki, O; Kida, J; Shiroshita, K; Uchida, S; Uemura, M | 1 |
| Araki, T; Koizumi, K; Nambu, A; Satoh, Y | 1 |
| Alongi, P; Bomanji, J; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Papathanasiou, N; Picchio, M; Zanoni, L | 1 |
| Liu, B; Servaes, S; Yang, H; Zhuang, H | 1 |
| Chen, Y; Huang, Z; Rao, M; Xiao, X; Zhu, Y | 1 |
| Hashimoto, J; Hayashi, N; Imai, Y; Iwaisako, K; Iwamoto, T; Kazama, T; Koizumi, J; Morioka, T; Niikura, N; Ogiya, R; Okamura, T; Oshitanai, R; Saito, Y; Terao, M; Tokuda, Y; Tsuda, B | 1 |
| Aukland, SM; Biermann, M; Boye, K; Johnsen, B; Rosendahl, K; Trovik, C | 1 |
| Ishidou, Y; Komiya, S; Nagano, S; Nakamura, S; Sasaki, H; Setoguchi, T; Shimada, H; Tsuchimochi, T; Yamamoto, T; Yokouchi, M | 1 |
| Cho, A; Kang, WJ; Park, JY; Park, YJ; Song, EH; Song, HT | 1 |
| Araujo, JC; Etchebehere, EC; Fox, PS; Macapinlac, HA; Rohren, EM; Swanston, NM | 1 |
| Hafezi-Nejad, N; Marcus, C; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Altrinetti, V; Bongioanni, F; DeCensi, A; Gennari, A; Gonella, R; Iacozzi, M; Massollo, M; Morbelli, S; Paparo, F; Piccardo, A; Puntoni, M; Sambuceti, G | 1 |
| Andersen, KF; Fuglo, HM; Loft, A; Petersen, MM; Rasmussen, SH | 2 |
| Cook, GJ; Grecchi, E; O'Doherty, J; Tsoumpas, C; Turkheimer, FE; Veronese, M | 1 |
| Chen, X; Mi, B; Niu, G; Pan, D; Wan, W; Yang, M; Yu, C | 1 |
| Bird, N; Buscombe, J; Cheow, HK; Eisen, T; Fife, K; Gallagher, FA; Gerety, EL; Heard, S; Hilborne, S; Lawrence, EM; Lomas, DJ; Matakidou, A; Shaw, AS; Soloviev, D; Wason, J; Yan, H | 1 |
| Bilska, K; Chaber, R; Drabko, K; Dziuk, M; Michalak, E; Muszyńska-Rosłan, K; Pogorzała, M; Połczyńska, K; Raciborska, A; Rodriguez-Galindo, C; Rychlowska-Pruszyńska, M; Sobol, G; Wieczorek, M | 1 |
| Emmadi, R; Lu, Y; Patel, D; VanDreel, A | 1 |
| Hutchinson, L | 1 |
| Alamgeer, M; David, S; Ganju, V; Ng, SP | 1 |
| Dieckmann, W; Kebebew, E; Nilubol, N; Patel, D; Satoh, K | 1 |
| Ishida, H; Ishihara, A; Iwasaki, R; Iwasaki, T; Kodama, Y; Mita, E; Nakazuru, S; Nishio, K; Sakakibara, Y; Yamada, T | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Fukukura, Y; Jinguji, M; Nakabeppu, Y; Nakajo, M; Tani, A; Yoshiura, T | 1 |
| Aprile, G; Fanotto, V; Fontanella, C; Puglisi, F; Rihawi, K | 1 |
| Dong, J; Li, J; Li, Z; Liu, F; Wang, B; Zhang, Q; Zhou, D; Zhu, D | 1 |
| Han, YJ; Li, HS; Wang, LJ; Wang, M; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Burger, IA; Hüllner, M; Queiroz, MA; Samarin, A; Stolzmann, P; Veit-Haibach, P; von Schulthess, G | 1 |
| Kato, O; Kunimatsu, J; Sato, T; Watanabe, R | 1 |
| Ghaderi, KF; Hart, J; Yoo, DC | 1 |
| Adams, S; Paryani, B; Subbiah, V; Takalkar, A | 1 |
| He, Q; Luo, G; Shi, X; Yi, C; Yu, D; Zhang, X | 1 |
| Benjamin, RS; Etchebehere, EC; Hobbs, BP; Macapinlac, HA; Malawi, O; Milton, DR; Patel, S | 1 |
| Kiyohara, H; Nakano, T; Ohno, T; Saito, K; Takagishi, K; Yanagawa, T | 1 |
| Andersen, JD; Lange, MB; Lilholt, HJ; Nielsen, ML; Petersen, LJ; Vyberg, M | 1 |
| Artiko, V; Grozdic-Milojevic, I; Obradovic, V; Odalovic, S; Pavlovic, S; Sobic Saranovic, D; Stojiljkovic, M; Susnjar, S | 1 |
| Baker, LH; Bolejack, V; Helman, LJ; Hyun O, J; Leal, JP; Luber, BS; Reinke, D; Schuetze, SM; Schwartz, LH; Wahl, RL; Wang, H | 1 |
| Al Bashir, S; Al-Muqbel, KM; Al-Omari, MH; Dagher, NM; Rousan, LA; Yaghan, RJ | 1 |
| Abouzied, ME; Al-Bulushi, NK | 1 |
| Servaes, S; Zhang, W; Zhuang, H | 1 |
| Araujo, JC; Erwin, WD; Etchebehere, EC; Fox, P; Macapinlac, HA; Milton, DR; Rohren, EM; Swanston, NM; Wendt, RE | 1 |
| Bochev, P; Chaushev, B; Dancheva, Z; Klisarova, A; Yordanova, T | 1 |
| Datz, L; Pirich, C; Rendl, G; Rettenbacher, L; Rodrigues, M; Stark, H; Studnicka, M | 1 |
| Fujii, S; Fukunaga, T; Matsuki, T; Michimoto, K; Ogawa, T; Sakamoto, H; Tahara, T; Tanino, T; Uchida, N | 1 |
| Chao, IM; Chen, ML; Hsieh, PJ; Hsieh, TS; Su, HY | 1 |
| Bier, G; Eigentler, T; Garbe, C; Hoffmann, V; Kloth, C; Klumpp, B; La Fougère, C; Nikolaou, K; Othman, AE; Pfannenberg, C | 1 |
| Furuta, T; Johan, MP; Kubo, T; Ochi, M | 1 |
| Doyle-Lindrud, S | 1 |
| Azad, GK; Cook, GJ | 1 |
| Bishop, MW; Daw, NC; Hurley, C; Mao, S; McCarville, MB; Navid, F; Pappo, AS; Shulkin, BL; Wu, J | 1 |
| Kok, TY; Neo, SH; Tong, AK | 1 |
| Byun, BH; Choi, CW; Hwang, JP; Jeon, DG; Kim, BI; Kong, CB; Lim, I; Lim, SM | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X; Zong, Z | 1 |
| Aktas, GE; Demir, SS; Oz Puyan, F; Sarikaya, A | 1 |
| Doi, H; Fukushima, K; Hirota, S; Kaibe, N; Kawanaka, Y; Kitajima, K; Miwa, H; Mouri, M; Niwa, H; Oshima, T; Sasako, M; Tomita, T | 1 |
| Cheng, X; Li, H; Wu, X | 1 |
| Anderson, TM; Lu, Y; Patel, D | 1 |
| Cheng, YS; Dai, YL; Li, YJ; Tu, CQ; Zhang, WB | 1 |
| Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
| Al-Muqbel, KM; Yaghan, RJ | 1 |
| Buchpiguel, CA; Coutinho, AM; de Menezes, MR; do Vale, RH; Queiroz, MA | 1 |
| Akdulum, I; Caglar, E; Cosar, ZS; Dilek, G; Kiziltepe, FT; Uylar, T | 1 |
| Andersen, KT; Hinge, M; Holdgaard, PC; Jørgensen, HB; Lund, T; Ormstrup, TE; Plesner, T; Østergaard, LL | 1 |
| Chen, WW; Cheng, MF; Chou, YH; Ko, KY; Yen, RF | 1 |
| Bader, T; Beck, M; Diebold, J; Egger-Sigg, M; Strobel, K | 1 |
| Ashamalla, M; Grimm, R; Hegener, P; Koutroumpakis, E; McCarthy, L; Mehdi, S | 1 |
| Adachi, E; Ikeda, Y; Kinjo, N; Kitagawa, D; Maehara, S; Mine, M; Nakamura, T; Ohgaki, K; Saitoh, G; Teramoto, S; Yoneshima, Y | 1 |
| Akers, WJ; Cenci, S; Civitelli, R; D'avignon, A; Fontana, F; Ge, X; Hathi, D; Shoghi, KI; Shokeen, M; Su, X; Weilbaecher, KN; Xiang, J | 1 |
| Berwouts, D; De Neve, W; De Wolf, K; Goethals, I; Lambert, B; Madani, I; Olteanu, LA; Ost, P; Speleers, B | 1 |
| Alauddin, Z; Fatima, N; Masood, M; Mirza, ZR; Qureshi, A; Shahid, A | 1 |
| Chen, YR; Hsieh, TC; Hsu, CN; Kao, CH; Kuo, YC | 1 |
| Kollàr, A; Langer, R; Sachpekidis, C; Wartenberg, J | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Han, J; Qin, L; Zhang, C; Zhao, H | 1 |
| Yoon, SN | 1 |
| Cambioli, S; Cevolani, L; Colangeli, M; De Paolis, M; Donati, D; Fanti, S; Ferrari, S; Gambarotti, M; Marchesi, E; Nanni, C; Paioli, A; Palmerini, E; Picci, P | 1 |
| Joy, A; Madhavan, J; Pillai, MR; Raman, V; Sasikumar, A; Vasudevan, A | 1 |
| Ansquer, C; Drui, D; Gahier Penhoat, M; Guillot, P; Maugars, Y; Mirallie, E | 1 |
| He, F; Liu, H; Liu, T; Meng, B; Shi, X; Wang, S; Yang, H; Zhou, F | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Aukland, SM; Biermann, M; Boye, K; Fasmer, KE; Johnsen, B; Rosendahl, K; Trovik, C | 1 |
| Hatanaka, KC; Hirata, K; Kanno-Okada, H; Manabe, O; Mitsuhashi, T; Mizumachi, T; Nakagawa, J; Oyama-Manabe, N; Tamaki, N | 1 |
| Iranmanesh, AM; Oates, ME; Wang, J | 1 |
| Alam, MS; Fu, L; Han, YJ; Li, HS; Ren, YY; Wang, QS; Wang, Z; Wu, HB; Zhou, WL | 1 |
| Bassa, P; Capdevila, L; Garcia, JR; Pérez, C; Ramos, F; Valenti, V | 1 |
| Dong, L; Han, T; Lin, Q; Liu, B; Liu, M; Wang, X | 1 |
| Hope, TA; Kaushik, SS; Larson, PE; Leynes, AP; Seo, Y; Shanbhag, DD; Wiesinger, F; Yang, J | 1 |
| Healey, JH; Kim, TW; Ulaner, GA; Zheng, J; Zindman, AM | 1 |
| Matsuoka, K; Miyamoto, Y; Ueda, M | 1 |
| Cistaro, A; Cogoni, M; Di Rosa, G; La Delfa, V; Quartuccio, N | 1 |
| Liu, Y | 1 |
| Kohli, PS; Mittal, BR; Roop, MJ; Singh, B; Singh, G; Singh, H; Watts, A | 1 |
| Krebs, S; Lewis, N; Luciano, A; Mannelli, L; Monti, S; Rastrelli, L | 1 |
| Benjamin, A; Chateil, JF; de Clermont-Gallerande, H; de Vaugelade, C; Ducassou, S; Fernandez, P; Meyer, M; My Duyen Tiphaine, A | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Eilber, FC; Evilevitch, V; Phelps, ME; Weber, WA | 1 |
| Mahmood, S; Martinez de Llano, SR | 1 |
| Agarwala, S; Bakhshi, S; Kumar, A; Kumar, J; Kumar, R; Seith, A; Sharma, R | 1 |
| Antich, PP; Slavine, NV | 1 |
| Li, W; Lin, N; Tian, M; Yang, D; Ye, Z; Zhan, H; Zhang, H; Zhao, C; Zhu, J | 1 |
| Madewell, JE; O'Sullivan, PJ; Rohren, EM | 1 |
| Bode, B; Exner, UE; Hany, TF; Hodler, J; Mende, K; Strobel, K; Stumpe, KD; Veit-Haibach, P; von Schulthess, GK | 1 |
| Hsu, CH; Leung, TK; Liew, PL; Wang, W; Yang, KM | 1 |
| Cho, IH; Choi, JH; Chun, KA; Han, DS; Shin, DS; Shon, OJ | 1 |
| Ferguson, PJ; Khanna, G; Sato, TS | 1 |
| Chen, MY; Fan, W; Liang, PY; Lin, XP; Zhang, X; Zhao, C; Zhi, SF | 1 |
| de Geus-Oei, LF; de Rooy, JW; Oyen, WJ; van de Luijtgaarden, AC; van der Graaf, WT | 1 |
| Arvanitis, C; Bendapudi, PK; Felsher, DW; Gambhir, SS; Tseng, JR | 1 |
| Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Myoui, A; Qiu, Y; Tomita, Y; Ueda, T; Yoshikawa, H; Zhang, B | 1 |
| Hicks, RJ; Kim, PJ; Mac Manus, MP; Prince, HM; Ryan, G; Seymour, JF; Wirth, A | 1 |
| Hameg, A; Le Stanc, E; Tainturier, C; Theodore, C; Vilain, D; Wattel, C | 1 |
| Frerich, B; Hemprich, A; Kluge, R; Sabri, O; Schulz, T; Steinhoff, K; Wilde, F; Winter, K | 1 |
| Choi, CM; Kim, WS; Oh, YM; Ryu, JS; Shim, TS; Song, JW | 1 |
| Kuang, A; Li, F; Li, L; Su, M; Tian, R; Tian, Y; Zeng, J | 1 |
| Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H | 1 |
| Eslamy, HK; Krupitskaya, Y; Kumar, A; Nguyen, DD; Wakelee, HA | 1 |
| Anderson, PM; Bassett, RL; Costelloe, CM; Fitzgerald, NE; Harrell, RK; Lewis, VO; Macapinlac, HA; Madewell, JE; Marom, EM; Mawlawi, OR; Raymond, AK; Rohren, EM | 1 |
| Harada, M; Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K | 1 |
| Fu, Z; Hu, M; Li, M; Liu, N; Ma, L; Pang, Q; Shi, F; Yang, G; Yu, J; Zhou, W | 1 |
| Patel, CN; Rankine, JJ; Scarsbrook, AF; Smith, JT | 1 |
| Flucke, U; Mus, R; Oyen, WJ; Van der Graaf, WT; Van Laarhoven, HW; Vinken, M | 1 |
| Abdel-Dayem, H; Libes, R; Lin, H; Mikhaeil, M; Mousavi, A; Piperkova, E; Rosen, G; Viejo-Rullan, F | 1 |
| Ben-Sellem, D; Constantinesco, A; Gangi, A; Imperiale, A; Mertz, L; Moser, T | 1 |
| D'Souza, M; Jaimini, A; Jain, N; Kaur, P; Mondal, A; Sharma, R; Singh, D; Singh, N; Tripathi, M | 1 |
| Ford, JM; Humke, E; Kim, J; Koong, AC; Quon, A | 1 |
| Goffin, E; Hermoye, A; Lecouvet, F; Lhommel, R; Lonneux, M; Malghem, J | 1 |
| Han, SK; Kim, YW; Min, JW; Shim, YS; Um, SW; Yim, JJ; Yoo, CG | 1 |
| Benz, MR; Czernin, J; Eilber, FC; Federman, N; Tap, WD; Tchekmedyian, N | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| Alpe, T; Anaissie, E; Angtuaco, E; Barlogie, B; Bartel, TB; Brown, TL; Crowley, J; Epstein, J; Haessler, J; Shaughnessy, JD; van Rhee, F; Walker, R | 1 |
| Lee, SK; Rho, BH | 1 |
| Buck, AK; Hasenkamp, E; Hombach, V; Krüger, S; Merk, T; Mottaghy, FM; Pauls, S; Reske, SN; Schumann, C; Wibmer, T | 1 |
| Butrynski, JE; Conrad, EU; Eary, JF; Hawkins, DS; Schuetze, SM | 1 |
| Alexiou, J; Flamen, P; Garcia, C; Gil, T; Huyge, V; Vanderstappen, A | 1 |
| Charest, M; Derbekyan, V; Hickeson, M; Lisbona, R; Novales-Diaz, JA; Turcotte, RE | 1 |
| Cristofanilli, M; De Giorgi, U; Doyle, GV; Handy, BC; Hortobagyi, GN; Macapinlac, HA; Mego, M; Miller, MC; Reuben, JM; Rohren, E; Ueno, NT; Valero, V | 1 |
| Aoyama, N; Koyama, H; Matsumoto, K; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Bischoff, G; Bischoff, M; Buck, A; Gebhard, F; Pauls, S; Reske, SN; Scheffold, F; Schultheiss, M; von Baer, A | 1 |
| Aurengo, A; Leenhardt, L; Lloret Linares, C; Sellier, P; Troisvallets, D | 1 |
| Decouvelaere, AV; Duclos, ME; Dutour, A; Marec-Bérard, P; Monteil, J; Roualdes, O; Rousseau, R | 1 |
| Cheon, GJ; Cho, WH; Jeon, DG; Kim, MS; Koh, JS; Lee, JA; Lee, SY; Oh, DH; Shin, DS; Song, WS; Yoo, JY | 1 |
| Chang, TC; Chen, MY; Chen, YR; Chou, HH; Hong, JH; Lai, CH; Liu, FY; Ng, KK; Yen, TC | 1 |
| Bassett, RL; Costelloe, CM; Fitzgerald, NE; Harrell, RK; Madewell, JE; Marom, EM; Mawlawi, OR; Nunez, RF; Raymond, AK | 1 |
| Landa, J; Schwartz, LH | 1 |
| Cook, G; deSouza, NM; Messiou, C | 1 |
| Brown, JM; Johnson, GH; Mitchell, LA | 1 |
| Martin, P | 1 |
| Irei, T; Kobashi, Y; Mouri, K; Oka, M; Shimizu, H | 1 |
| Goodin, GS; Hudson, MM; Kaste, SC; Krasin, MJ; McCarville, MB; Metzger, M; Shulkin, BL | 1 |
| Antoch, G; Bockisch, A; Eberhardt, W; Esser, S; Forsting, M; Gölitz, P; Hamami, M; Heusner, T | 1 |
| Chua, S; Cook, GJ; Gnanasegaran, G | 1 |
| Ak, I; Entok, E; Sivrikoz, MC; Vardareli, E | 1 |
| Dua, SG; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
| De La Mota, J; Espaillat-Rijo, L; Hernandez, E; Micaily, B; Thomas, MB | 1 |
| Strobel, K | 1 |
| Hara, T; Ishizu, K; Nakamoto, Y; Suga, T; Togashi, K | 1 |
| Kishimoto, S; Kubota, T; Matsushima, S; Nishida, K; Nishimura, T; Oda, M; Okuyama, C; Takenaka, H | 1 |
| Iizuka, Y; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Eftekhari, F | 1 |
| Küçüköz Uzun, A; Ozpaçac, T; Ozülker, F; Ozülker, T | 1 |
| Appelbaum, DE; Ilkhchoui, Y; Pu, Y | 1 |
| Inoue, T; Kawaguchi, M; Shizukuishi, K; Suzuki, A; Tateishi, U | 1 |
| Avram, A; Djekidel, M; Gordon, M; Gross, MD; Shah, RB | 1 |
| Izuishi, K; Masaki, T; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Bartolucci, AD; Calabria, F; Mammucari, M; Masala, S; Schillaci, O; Simonetti, G | 1 |
| Cheng, T; Liu, J; Liu, T; Xu, W; Yan, WL; Yang, HL | 1 |
| Amthauer, H; Beck, JF; Bierbach, U; Denecke, T; Franzius, C; Furth, C; Hautzel, H; Henze, G; Hundsdörfer, P; Kluge, R; Misch, D; Otto, S; Plotkin, M; Ruf, J; Schönberger, S; Steffen, IG; Stöver, B | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Dua, S; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
| Alexiou, J; Ameye, L; Awada, A; Bergmann, P; Body, JJ; Flamen, P; Garcia, C; Huyge, V; Lemort, M; Vanderlinden, B | 1 |
| Bradley, KM; Lakkaraju, A; Patel, CN; Scarsbrook, AF | 1 |
| Cristofanilli, M; De Giorgi, U; Handy, BC; Hortobagyi, GN; Liu, P; Macapinlac, HA; Mego, M; Reuben, JM; Rohren, EM; Ueno, NT | 1 |
| Fan, QP; Kuang, AR; Li, FL; Li, L; Miller, JH; Su, MG; Tian, R; Tian, Y | 1 |
| Hong, TS; Navarro, OM; Punnett, A; Shammas, A | 1 |
| Franzius, C | 1 |
| Ayala-Ramirez, M; Chuang, H; Habra, MA; Jimenez, C; Kyle, K; Núñez, R; Rich, T | 1 |
| Fox, JJ; Gönen, M; Humm, J; Larson, SM; Meirelles, GS; Morris, MJ; Ravizzini, GC; Scher, HI; Schöder, H | 1 |
| Chen, S; Cheng, TK; Ho, CL; Leung, YL | 1 |
| Alaee, F; Chatziioannou, AF; Dougall, WC; Lieberman, JR; Petrigliano, FA; Stout, D; Sugiyama, O; Virk, MS | 1 |
| Aerts, J; Giacomelli, F; Grayet, B; Hustinx, R; Jerusalem, G; Mella, C; Mievis, F; Rorive, A; Tancredi, T; Waltregny, D; Withofs, N | 1 |
| Bai, YR; Liu, T; Xu, JY; Xu, W; Yan, WL; Yang, HL | 1 |
| Christensen, T; Ewertz, M; Fisker, R; Fründ, ET; Grankvist, J; Iyer, V; Larsson, EM; Simonsen, C; Stenbygaard, L | 1 |
| Agko, M; Aybar, PS; Chaudhuri, PK; Higgins, JA; Nazzal, M; Slam, K | 1 |
| Hasuo, K; Ito, K; Kikuchi, Y; Kubota, K; Minamimoto, R; Morooka, M; Oka, S; Shida, Y; Teruya, K; Yanagisawa, K | 1 |
| Dua, SG; Purandare, N; Rangarajan, V; Shah, S; Sharma, AR; Zade, AA | 1 |
| Eary, JF; Hackenbracht, JA; Higano, CS; Link, JM; Mankoff, DA; Montgomery, RB; Muzi, M; Rezvani, BB; Yu, EY | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Choong, PF; Di Bella, C; Gaston, LL; Hicks, RJ; Slavin, J | 1 |
| Aro, H; Böhling, T; Elomaa, I; Kallajoki, M; Kivioja, A; Lindholm, P; Mattila, K; Minn, H; Oikonen, V; Sutinen, E; Tarkkanen, M | 1 |
| Dai, K; Huang, X; Qu, X; Wu, L; Yan, W | 1 |
| Kawaguchi, Y; Kawase, Y; Maeda, Y; Nishiyama, Y; Yamamoto, Y | 1 |
| Dick, DW; Gambhir, SS; Iagaru, A; Mittra, E | 1 |
| Ciarallo, A; Lisbona, R; Makis, W | 1 |
| Andreopoulos, D; Frangos, S; Giannopoulou, E; Lutz, S; Tselis, N; Vassiliou, V | 1 |
| de Geus-Oei, LF; de Rooy, JW; Flucke, UE; Hambrock, T; Schreuder, BW; van de Luijtgaarden, AC; van der Geest, IC; Vriens, D | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H; Leblond, P; Rocourt, N | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Bao, L; Cheng, X; Li, D; Li, Y; Wang, J; Xu, Z | 1 |
| Cimarelli, S; Deshayes, E; Giammarile, F; Mognetti, T; Ricard, F; Thiesse, P | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Vliegen, RF | 1 |
| Endo, K; Tian, M; Zhang, H | 1 |
| Leitzin, L; Peer, A; Shai, A; Shalom, RB; Srour, S; Steiner, M | 1 |
| Berenger, N; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Misset, JL; Toubert, ME; Vercellino, L | 1 |
| Deng, SM; Liu, T; Wang, XM; Xu, Y; Yang, HL | 1 |
| Hoekstra, OS; Regelink, JC; Riphagen, II; van Lammeren-Venema, D; Zijlstra, JM; Zweegman, S | 1 |
| Chen, HY; Hsieh, TC; Hsu, CN; Wu, YC; Yang, CF | 1 |
| Barna, S; Borbély, K; Garai, I; Hascsi, Z; Illés, A; Szûcs, B; Tóth, Z | 1 |
| Allen-Auerbach, M; Apichairuk, W; Czernin, J; Federman, N; Nelson, S; Phelps, ME; Walter, F; Walter, MA | 1 |
| Im, HJ; Kang, HG; Kim, JH; Kim, SK; Kim, TS; Kwon, MM; Min, HS; Park, BK; Park, HJ; Park, SE; Park, SY; Yoon, JH | 1 |
| Fioole-Bruining, A; Hoefnagel, CA; Koolen, BB; Rutgers, EJ; Stokkel, MP; Valdés Olmos, RA; Vegt, E; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Antoch, G; Bockisch, A; Boy, C; Forsting, M; Hahn, S; Heusner, T; Köninger, A; Kümmel, S; Müller, S; Nagarajah, J; Stahl, A | 1 |
| Eshuis, SA; Gemmel, F; Gemmel, P; van Vollenhoven, F | 1 |
| Cornelissen, C; Frechen, D; Krüger, S; Kweider, S; Temur, Y | 1 |
| Kim, SH; Mulligan, ME; Smith, SE | 1 |
| Bonomo, L; Giordano, A; Mattoli, MV; Salsano, M; Stefanelli, A; Treglia, G | 1 |
| Altrinetti, V; Corradengo, D; De Censi, A; Gennari, A; Piccardo, A; Villavecchia, G | 1 |
| Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
| Cross, S; Dalla-Pozza, L; Graf, N; Howman-Giles, R; Kaspers, G; London, K; Onikul, E; Stege, C | 1 |
| Allen-Auerbach, M; Czernin, J; Dunkelmann, S; Federman, N; Hall, T; Walter, F; Walter, MA | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Lin, CC; Yang, KT; Yeh, JJ | 1 |
| Gogbashian, A; Padhani, AR | 1 |
| Bajpai, J; Bakhshi, S; Gamnagatti, S; Khan, SA; Kumar, R; Malhotra, A; Rastogi, S; Safaya, R; Sharma, MC; Sreenivas, V | 1 |
| Chezal, JM; Dauplat, MM; Gouin, F; Heymann, D; Miot-Noirault, E; Redini, F | 1 |
| Braziewicz, J; Hołody, Ł; Królicki, L; Tarnawska-Pierścińska, M | 1 |
| Altrinetti, V; Bacigalupo, L; Biscaldi, E; Cabria, M; DeCensi, A; Gozza, A; Iacozzi, M; Morbelli, S; Pasa, A; Piccardo, A; Puntoni, M; Villavecchia, G | 1 |
| Abikhzer, G; Alabed, YZ; Lisbona, R; Nahal, A; Rakheja, R | 1 |
| Fig, LM; Komissarova, M; Wong, KK | 1 |
| Montini, KM; Tulchinsky, M | 1 |
| Antoch, G; Bölke, E; Budach, W; Gerber, PA; Hautzel, H; Kröpil, P; Matuschek, C; Scherer, A; Zinnmann, F | 1 |
| Attinà, G; Calcagni, ML; Coccia, P; Leccisotti, L; Marano, R; Maurizi, P; Natale, L; Riccardi, R; Rufini, V; Ruggiero, A | 1 |
| Cha, JG; Kim, HK; Paik, SH; Park, JM; Park, SJ; Yoo, JH | 1 |
| Codreanu, I; Servaes, S; Yang, J; Zhuang, H | 1 |
| Katayama, T; Kubota, K; Machida, Y; Shibuya, H; Toriihara, A | 1 |
| Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Burger, C; Burger, IA; Crook, DW; Kuhn, FP; Samarin, A; Schmid, DT; von Schulthess, GK; Wollenweber, SD | 1 |
| Cristofanilli, M; De Giorgi, U; Giordano, A; Giuliano, M; Hortobagyi, GN; Mego, M; Reuben, JM; Scarpi, E; Ueno, NT; Valero, V | 1 |
| Alavi, A; Codreanu, I; Torigian, DA; Zhuang, H | 1 |
| Dewar, R; Freedman, AS; Giardino, AA; Mauch, P; Ramaiya, NH; Shinagare, AB; Shinagare, SA; Weckstein, D | 1 |
| Kleijnen, J; Paschen, U; Sauerland, S; Westwood, M; Wolff, R | 1 |
| Bom, HS; Byun, BH; Chong, A; Hong, SP; Kang, SR; Kim, J; Min, JJ; Oh, JR; Song, HC; Yoo, SW | 1 |
| Fuglø, HM; Hovgaard, D; Jørgensen, SM; Loft, A; Petersen, MM | 1 |
| Bae, WK; Kim, YH; Lee, HS; Lee, JW; Lee, SM | 1 |
| Cha, SW; Cho, YD; Choi, DL; Jang, JY; Jeong, SW; Jin, SY; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, JE; Lee, SH | 1 |
| Brach Del Prever, A; Cistaro, A; Fagioli, F; Fania, P; Gastaldo, L; Lopci, E | 1 |
| Bom, HS; Choi, YD; Chong, A; Ha, JM; Lee, JS; Min, JJ; Oh, JR; Song, HC | 1 |
| Hata, K; Hoshi, M; Ieguchi, M; Nakamura, H; Oebisu, N; Takada, J | 1 |
| Aina, H; Bingshun, W; Daliu, M; Hongtao, L; Hui, Z; Shuier, Z; Xiaojin, W; Yang, Y; Yuanjue, S; Zan, S; Zhiyu, W | 1 |
| Lewis, DH; Reeve, IP; Zhang, Y | 1 |
| Li, C; Li, P; Qian, Y; Shi, Y; Wu, H; Wu, Y; Yang, J; Zhang, H; Zhang, J | 1 |
| Revannasiddaiah, S; Sharma, M; Sood, A; Thakur, P | 1 |
| Amorim, BJ; Barboza, MF; Bortot, DC; Etchebehere, EC; Gapski, SB; Lima, MC; Mengatti, J; Oki, GC; Ramos, CD; Santos, AO | 1 |
| Gámez Cenzano, C; García del Muro, FJ; Narváez García, JA; Rodríguez Bel, L; Sabaté Llobera, A | 1 |
| Chan, SC; Hsu, CL; Liao, CT; Lin, CY; Lin, YJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Hayashi, A; Hiruta, N; Inaoka, T; Kudo, H; Nakagawa, K; Terada, H; Tokuyama, W | 1 |
| Anai, S; Harada, T; Ijichi, K; Koga, T; Kubo, N; Nakanishi, Y; Otsubo, K; Takayama, K; Yoneshima, Y | 1 |
| Banks, KP; Clemenshaw, MN; Craun, JB; Moren, RW | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Kara Gedik, G; Kaya, B; Ozcan Kara, P; Sari, O; Varoglu, E | 1 |
| Ahlström, H; Johansson, S; Mosavi, F; Sandberg, DT; Sörensen, J; Turesson, I | 1 |
| Costelloe, CM; Hamaoka, T; Hayashi, N; Hortobagyi, GN; Madewell, JE; Niikura, N; Theriault, RL; Ueno, NT; Wei, C | 1 |
| Luo, QY; Qiu, ZL; Song, HJ; Xue, YL | 1 |
| Caldarella, C; Isgrò, MA; Treglia, G; Treglia, I | 1 |
| Chen, ZF; Luo, BQ; Rao, LJ; Shi, XC; Wang, XY; Yi, C; Zhang, XS | 1 |
| Abramson, S; Arora, VC; Fleming, S; LaQuaglia, MP; Magnan, H; Price, AP; Sohn, MJ | 1 |
| Hawkins, DS; Jones, RL; Newman, EN | 1 |
| Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H | 1 |
| Al-Ibraheem, A; Beer, AJ; Benz, MR; Buck, AK; Haller, B; Herrmann, K; Juenger, H; Mansour, A; Pomykala, KL; Rudert, M; Scheidhauer, K; Schwaiger, M | 1 |
| Tewari, S; Ulaner, GA | 1 |
| de Lima, JM; Dick, DW; Gambhir, SS; Iagaru, A; Isidoro, J; Iyer, V; Lapa, P; Mittra, E; Mosci, C; Prakash, V; Sathekge, M | 1 |
| Brillet, E; Decaux, O; Duvauferrier, R; Guillin, R; Marchand, A; Niederberger, E; Patrat-Delon, S; Rescan, M; Valence, M | 1 |
| Anaissie, E; Barlogie, B; Bartel, T; Brown, T; Crowley, J; Hoering, A; Mitchell, A; Petty, N; Usmani, SZ; van Rhee, F; Waheed, S | 1 |
| Akashi, K; Harada, Y; Kamezaki, K; Ohshima, K; Shimono, N | 1 |
| Baldwin, J; Blaydorn, L; Downhour, M; Hoff, DD; Korn, RL; Thacker, CA; Tibes, R; Weiss, GJ; White, E | 1 |
| Bonardel, G; Chargari, C; Foehrenbach, H; Le Moulec, S; Védrine, L | 1 |
| Mojtahedi, A; Solomon, SB; Ulaner, GA | 1 |
| Andreopoulou, P; Bhattacharyya, N; Boyce, AM; Chang, R; Chen, CC; Chong, WH; Collins, MT; Crespo, DO; Dwyer, A; El-Maouche, D; Gafni, RI; Guthrie, L; Kelly, M; Kletter, GB; Reynolds, J; Sherry, R; Wodajo, FM | 1 |
| Al-Nabhani, K; Almukhailed, O; Bomanji, J; Haroon, A; Syed, R | 1 |
| Abolmaali, N; Froehner, M; Wirth, MP | 1 |
| Chang, J; Chen, J; Lew, P; Shim, JJ; Vasinrapee, P | 1 |
| Akhurst, T; Etchebehere, EC; Gonen, M; Humm, K; Larson, SM; Macapinlac, HA; Scher, HI; Yeung, HW | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Hawkins, DS; Rajendran, JG | 1 |
| De Cobelli, F; Fazio, F; Gianolli, L; Landoni, C; Maschio, AD; Matarrese, M; Messa, C; Picchio, M | 1 |
| Bielack, S; Flege, S; Franzius, C; Jürgens, H; Schober, O; Sciuk, J | 1 |
| Dunnwald, LK; Gralow, JR; Livingston, RB; Mankoff, DA; Rinn, KJ; Schubert, EK; Stafford, SE | 1 |
| Bruckner, JD; Chandhury, KR; Conrad, EU; Eary, JF; O'Sullivan, F; Powitan, Y; Vernon, C | 1 |
| Bruns, J; Dobrowolskij, D; Jenicke, L; Niggemeyer, O | 1 |
| Kao, CH; Lee, CC; Lin, CC; Shen, YY; Wu, HC; Yen, RF | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Gratz, FW; Knapp, WH; Otto, D | 1 |
| Blake, M; Bushnell, D; Graham, MM; Johnson, J; Juweid, ME; Madsen, M; Menda, Y; O'Dorisio, MS | 1 |
| Changlai, SP; Hsia, TC; Kao, CH; Shen, YY; Yen, RF | 1 |
| Bredella, MA; Caputo, GR; Steinbach, LS | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Blum, R; Hicks, RJ; Seymour, JF | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
| Fogelman, I; Shon, IH | 1 |
| Delbeke, D; Fordice, S; Lamar, R; Ludwig, V; Martin, WH | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Watanabe, H; Zhang, H | 1 |
| Maschek, W; Pichler, R; Schmekal, B; Sfetsos, K; Weiglein, K | 1 |
| Nakamoto, Y; Osman, M; Wahl, RL | 1 |
| Feldman, F; Manos, C; van Heertum, R | 1 |
| Aoki, J; Endo, K; Kato, K | 1 |
| Franzius, C; Schober, O | 1 |
| Bourguet, P | 2 |
| Ahmed, AR; Aoki, J; Endo, K; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Bohuslavizki, KH; Brenner, W; Eary, JF | 1 |
| Grünwald, F; Hamscho, N | 1 |
| Espiritu, JI; Segall, GM; Sung, J; Terris, MK | 1 |
| Aizer-Dannon, A; Bar-Am, A; Even-Sapir, E; Flusser, G; Ron, IG | 1 |
| Coleman, RE; Kitapci, MT | 1 |
| Bakheet, R; Bakheet, SM; Baslaim, MM; El-Foudeh, M; Ezzat, A; Tulbah, A | 1 |
| Cohade, C; Fayad, LM; Fishman, EK; Wahl, RL | 1 |
| Kransdorf, MJ; O'Connor, MI; Peterson, JJ | 1 |
| Gordon, LL; Pope, TL; Ravenel, JG; Reed, CE | 1 |
| Garcia, JR; Lomeña, F; Lopez, S; Perez, G; Setoain, X; Simo, M; Soler, M | 1 |
| Argiris, A; Mellott, A; Spies, S | 1 |
| Bastiaannet, E; Cobben, DC; Groen, H; Hoekstra, HJ; Jager, PL; Vaalburg, W; van der Graaf, WT | 1 |
| Akhurst, TA; Beattie, B; Bornmann, W; Dyke, J; Erdi, Y; Finn, RD; Gunther, I; Humm, JL; Larson, SM; McCarthy, T; Morris, M; Pentlow, K; Scher, H; Squire, O; Welch, M | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Chim, CS; Liang, R; Loong, F; Ooi, GC | 1 |
| Brenner, W; Conrad, EU; Eary, JF | 1 |
| Cheran, SK; Herndon, JE; Patz, EF | 1 |
| Cesnik, R; Frühwald, F; Leitha, T; Steiner, E | 1 |
| Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Littrup, PJ; Taub, JW; Westphal, SM; Zak, IT; Zingas, AP | 1 |
| Berlangieri, SU; Foo, SS; Ramdave, S; Scott, AM | 1 |
| Baum, RP; Hellwig, D; Mezzetti, M | 1 |
| Aktolun, C; Berk, F; Bohuslavizki, KH; Clausen, M; Daugaard, G; Demir, H; Harmer, C; Lassen, U; Malamitsi, J; Peters, M; Plowman, PN; Raderer, M | 1 |
| Lehmann, K; Meller, J; Sahlmann, CO; Siefker, U | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Reiman, RE | 1 |
| Brenner, W; Conrad, EU; Eary, JF; Link, JM; Mankoff, DA; Muzi, M; Vernon, C | 1 |
| Conti, PS; Gamie, S; Jadvar, H; Ramanna, L | 1 |
| Futatsubashi, M; Kanno, T; Nakamura, F; Nakamura, S; Sakahara, H; Sugiyama, M; Torizuka, T | 1 |
| Chang, SS; Fawwaz, R; Lee, FY; Parisien, MV; Yu, J | 1 |
| Choi, SJ; Kim, HT; Park, YH; Ryoo, BY | 1 |
| Cho, SB; Chung, KY; Lee, MG; Yun, M | 1 |
| An, YS; Joh, CW; Lee, MH; Yoon, JK; Yoon, SN | 1 |
| Cook, G; Fogelman, I; Israel, O; Van der Wall, H | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
| Khuri, F; Saba, N | 1 |
| Aramaki, T; Endo, M; Furukawa, H; Morimoto, N; Uchida, Y; Uematsu, T; Watanabe, J; Yuen, S; Yukisawa, S | 1 |
| Cheon, GJ; Choi, CW; Choi, SJ; Kim, S; Lee, SS; Lim, SM; Park, YH; Ryoo, BY; Yang, SH; Yoo, JY | 1 |
| Feldman, F; Parisien, M; Saxena, C; Van Heertum, R | 1 |
| Brink, I; Ghanem, N; Kelly, T; Langer, M; Moser, E; Schäfer, O; Uhl, M | 1 |
| Alavi, A; Cheng, E; Dhurairaj, T; Kumar, R; Yu, JQ; Zhuang, H | 1 |
| Finger, PT; Kurli, M; Pavlick, AC; Reddy, S; Tena, LB | 2 |
| Eberhard, S; Gönen, M; Herrmann, K; Hricak, H; Larson, SM; Scardino, P; Scher, HI; Schöder, H | 1 |
| Fujii, T; Mochizuki, T; Morishige, I; Shigesawa, T; Shinohara, I; Sugawara, Y | 1 |
| Alavi, A; Aydin, A; Yu, JQ; Zhuang, H | 1 |
| Eyrich, GK; Goerres, GW; Schmid, DT; Schuknecht, B | 1 |
| Fogelman, I | 1 |
| García, JR; Lomeña, F; López, S; Pérez, G; Simó, M; Soler, M | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Suzuki, T; Taniike, K; Ushijima, Y; Yamada, K | 1 |
| Heiba, SI; Katzel, JA | 1 |
| Hall, FM | 1 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Guigay, J; L'Her, P; Mantzarides, M; Salles, Y; Vaylet, F | 1 |
| Hsu, CH; Lee, CM; Lee, TJ; Lou, HY | 1 |
| Cohade, C; Hammoud, D; Nakamoto, Y; Tatsumi, M; Wahl, RL | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K | 1 |
| Smith, S; Williams, HT | 1 |
| Butrynski, JE; Conrad, EU; Eary, JF; Hawkins, DS; Rajendran, JG; Schuetze, SM; Vernon, CB | 1 |
| Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Inoue, A; Myoui, A; Tamai, N; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Brink, I; Györke, T; Lange, A; Makó, E; Moser, E; Schäfer, O; Zajic, T | 1 |
| Gupta, C; Gupta, V; Malani, AK; Rangineni, S | 1 |
| Fogelman, I; Heinisch, M; Langsteger, W | 1 |
| Abe, K; Baba, S; Hayashi, K; Honda, H; Koga, H; Kuwabara, Y; Sasaki, M; Takahashi, N | 1 |
| Liao, SQ; Liu, RS; Su, HY; Wang, SJ | 1 |
| Arens, A; de Jong, J; Kremer, B; Lambin, P; Thimister, P; van Baardwijk, A; Verseput, G | 1 |
| Ell, PJ | 1 |
| Fujimoto, K; Hirao, Y; Hirayama, A; Matsushita, C; Miyake, M; Nonomura, A; Takashima, K; Tanaka, M | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Liao, CT; Liu, FY; Ng, SH; Ng, SK; Wang, HM; Yen, TC | 1 |
| Cangini, D; Canini, R; Castellucci, P; Cavo, M; Fanti, S; Farsad, M; Nanni, C; Salizzoni, E; Tosi, P; Zamagni, E | 1 |
| Arai, Y; Hasegawa, T; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U | 1 |
| Borgen, P; Caravelli, J; Gonen, M; Larson, S; Liberman, L; Port, ER; Yeung, H | 1 |
| McCarville, B | 1 |
| Batra, K; Chhabra, A; Makler, PT | 1 |
| Masaoka, T; Sato, T; Shiono, S; Yanagawa, N | 1 |
| Cangelosi, CJ; Lin, YG; Musana, KA; Raja, S | 1 |
| Connolly, LP; Drubach, LA; Kourmouzi, V; Voss, SD | 1 |
| Bar-Shalom, R; Fogelman, I; Goldberg, A; Israel, O; Keidar, Z; Militianu, D; Nachtigal, A | 1 |
| Aflalo-Hazan, V; Frétault, J; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Raileanu, I; Talbot, JN | 1 |
| Carrino, JA; Lang, PK; Pezeshk, P; Ready, JE; Sadow, CA; Winalski, CS | 1 |
| Akino, H; Aoki, Y; Fujibayashi, Y; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Okazawa, H; Oyama, N; Shioyama, R; Tanase, K; Yokoyama, O; Yonekura, Y | 1 |
| Gamie, S; Iagaru, A; Segall, G | 1 |
| Davidson, T; Goshen, E; Yeshurun, M; Zwas, ST | 1 |
| Brown, RK; Morag, Y; Walsh, MA | 1 |
| Fujimoto, R; Fujita, T; Hara, T; Higashi, T; Ishizu, K; Kawase, S; Kawashima, H; Lyshchik, A; Nakamoto, Y; Saga, T; Togashi, K | 1 |
| Chen, TH; Chen, WY; Hsu, HC; Hsu, YC; Huang, TL; Liu, RS | 1 |
| Goodin, GS; Kaufman, RA; McCarville, MB; Shulkin, BL | 1 |
| Plukker, JT; van Westreenen, HL | 1 |
| Berthelsen, AK; Daugaard, G; Fischer, BM; Hansen, HH; Langer, SW; Lassen, U; Loft, A; Mortensen, J; Petersen, BI | 1 |
| Sakata, K; Shimizu, N; Yamamoto, I | 1 |
| Gambhir, SS; Iagaru, A; McDougall, IR; Quon, A | 1 |
| Lin, EC | 1 |
| Duet, M; Faraggi, M; Lioté, F; Pouchot, J | 1 |
| Baccarani, M; Brioli, A; Buttignol, S; Cangini, D; Castellucci, P; Cavo, M; Ceccolini, M; Englaro, E; Fanin, R; Fanti, S; Geatti, O; Nanni, C; Patriarca, F; Perrone, G; Salizzoni, E; Tacchetti, P; Tosi, P; Zamagni, E | 1 |
| Arush, MW; Bar-Shalom, R; Israel, O; Meller, I; Militianu, D; Postovsky, S; Sapir, AE; Zaidman, I | 1 |
| Dunnwald, LK; Ellis, GK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK; Specht, JM; Tam, SL | 1 |
| Matsusita, M; Takagishi, K; Takeuchi, K | 1 |
| Argiris, A; Gooding, W; Kut, V; Spies, S; Spies, W | 1 |
| Alavi, A; Bing, Z; Chamroonrat, W; Houseni, M; Yang, H; Zhuang, H | 1 |
| Arai, Y; Hamashima, C; Kim, EE; Maeda, T; Moriyama, N; Sugimura, K; Tateishi, U; Terauchi, T | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SY; Nam, SY; Roh, JL | 1 |
| Gambhir, SS; Herfkens, RJ; Quon, A; Taira, AV | 1 |
| Alavi, A; Basu, S | 1 |
| Chen, YK; Kao, CH; Shen, YY; Sun, SS | 1 |
| Hicks, RJ; Hogg, A; Januszewicz, H; Lee, M; Macmanus, M; Ng, AP; Prince, HM; Seymour, JF; Wirth, A; Wolf, M | 1 |
| Berthelsen, AK; Engelholm, SA; Højgaard, L; Knudsen, J; Loft, A; Lundvall, L; Nedergaard, L; Ottosen, C; Roed, H | 1 |
| Chen, S; Cheng, TK; Ho, CL; Yeung, DW | 1 |
| Abe, S; Ikeda, M; Ishigaki, T; Ito, S; Iwano, S; Kato, K; Makino, N; Naganawa, S; Nakano, S; Nishino, M; Tadokoro, M | 1 |
| Jeong, HJ; Lim, ST; Sohn, MH; Song, SH; Yim, CY | 1 |
| Balogova, S; Cussenot, O; Gattegno, B; Grahek, D; Gutman, F; Huchet, V; Kerrou, K; Kerrouche, N; Montravers, F; Talbot, JN; Thibault, P | 1 |
| Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T | 1 |
| Lucignani, G | 1 |
| Cullum, I; Du, Y; Ell, PJ; Illidge, TM | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Dierckx, RA; Jager, PL; Links, TP; Phan, HT; Plukker, JT; Wolffenbuttel, BH | 1 |
| Chung, SK; Lee, SY; Lim, CH; Park, YH | 1 |
| Schirrmeister, H | 1 |
| Banavali, S; Basu, S; Nair, N | 1 |
| Basu, D; McDonald, DJ; Nussenbaum, B; Siegel, BA | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindie, E; Misset, JL; Moretti, JL; Toubert, ME; Vercellino, L | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Halaç, M; Mut, SS; Ozer, H; Sönmezoglu, K; Uslu, I; Ylmaz, MH | 1 |
| Nguyen, BD; Wiesenthal, AA | 1 |
| Alavi, A; Basu, S; Torigian, D | 1 |
| Fujii, M; Kiura, K; Takeda, H; Takigawa, N; Tanimoto, M | 1 |
| Fujishita, M; Fujishita, T; Kishida, M; Kobayashi, M; Maruyama, M; Miyabayashi, K; Mizushima, Y; Shinoda, C; Taki, H | 1 |
| Grohé, C; Ko, Y; Palmedo, H; Tasci, S | 1 |
| Arai, Y; Kim, EE; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U | 1 |
| Jeon, DG; Kim, MS; Lee, SY; Sim, YS | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T | 1 |
| Demir, H; Gorur, GD; Halac, M; Sonmezoglu, K; Uslu, I | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, JD; Rha, SY; Yoon, KT; Yun, M | 1 |
| Chawla, SP; Conti, PS; Fedenko, A; Iagaru, A; Masamed, R; Menendez, LR | 1 |
| Bredella, MA; Kattapuram, S; Nielsen, GP; Ouellette, HA; Sheah, K; Torriani, M | 1 |
| Inoue, T; Lee, J; Shizukuishi, K; Takahashi, N; Yamaguchi, T | 1 |
| Chen, YW; Chou, SH; Hou, MF; Hsieh, JS; Huang, MY; Lin, CL | 1 |
| Abdulrahim, N; Brandon, D; Cardarelli, R; Erdman, W; Shie, P | 1 |
| Peterson, JJ | 1 |
| Baarslag, HJ; Creyghton, W; de Haas, M; de Klerk, J; Kemps, B; Rinkes, IB; van Ufford, HQ | 1 |
| Dobashi, Y; Sato, J; Takagishi, K; Watanabe, H; Yamaji, T; Yanagawa, T | 1 |
| Colomo, L; Combalia-Aleu, A; Conill, C; Marruecos, J; Maurel, J; Palacín, A; Pomés, J; Setoain, X; Vargas, M | 1 |
| Byun, SJ; Cho, IH; Choi, JH; Chun, KA; Shin, DS; Shon, OJ | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
| Bae, DS; Huh, SJ; Lee, JA; Oh, D | 1 |
| Even-Sapir, E | 1 |
| Chua, SC; Ganatra, RH; O'Connor, SR; Wong, WL | 1 |
| Cristofanilli, M; Dawood, S; Gamez, C; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
| Mulligan, ME; Smith, S; Talmi, D | 1 |
| Brown, KL; Eary, JF; Gorlick, R; Grier, HE; Kailo, MD; Lawlor, ER; Lessnick, SL; Marina, N; Meyer, JS; Nadel, HR; Randall, RL; Schomberg, PJ; Womer, RB | 1 |
| Imabayashi, E; Kuji, I; Matsuda, H; Minagawa, A; Miyauchi, T | 1 |
| Gast, T; Hubner, K; Meyer, M; Raja, S | 1 |
| Fukumura, T; Ichiya, Y; Kawai, Y; Koga, H; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
| McClaughry, P; Meyer, MA | 1 |
| Gross, MD; Grossman, HB; Shreve, PD; Wahl, RL | 1 |
| Dehdashti, F; Fusselman, MJ; Griffeth, LK; McGuire, AH; McGuire, DJ; Siegel, BA; Trask, DD | 1 |
| Brizel, DM; Charles, HC; Coleman, RE; Dewhirst, MW; Friedman, HS; Harrelson, JM; Jones, DN; Layfield, L; McCowage, GB; Prescott, DM; Scully, SP; Sostman, HD | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Garcia, R; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Finn, RD; Garza, D; Goldsmith, SJ; Horowitz, SM; Imbriaco, M; Kalaigian, H; Larson, SM; Reddy, D; Scher, HI; Yeh, SD; Zhang, JJ | 1 |
| Altmann, A; Haberkorn, U; Kaick, GV; Klenner, T; Oberdorfer, F; Stöhr, M; Strauss, LG; Wallich, R | 1 |
| Cook, GJ; Fogelman, I; Maisey, MN | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Fujiwara, T; Fukuda, H; Ishii, K; Itoh, M; Kitamura, K; Miyake, M; Orihara, H; Satoh, T; Seo, S; Takahashi, S; Tanaka, K; Watanuki, S; Yamamoto, S | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Glaspy, JA; Hoh, CK; Maddahi, J; Moon, DH; Phelps, ME; Silverman, DH | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Vaalburg, W; van Horn, JR | 1 |
| Fogelman, I; Jacobson, AF | 1 |
| Barreto, A; Barthelemy, N; Bury, T; Daenen, F; Ghaye, B; Rigo, P | 1 |
| al Roubaie, Z; Chapot, C; Kirsch, CM | 1 |
| Altehoefer, C; Hoegerle, S; Juengling, F; Moser, EA; Nitzsche, EU; Otte, A | 1 |
| Cook, GJ; Fogelman, I; Houston, S; Maisey, MN; Rubens, R | 1 |
| Endo, K; Inoue, T; Masuda, H; Oriuchi, N; Shimizu, N; Yamanaka, H | 1 |
| Cook, GJ; Fogelman, I | 4 |
| Dietlein, M; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Smolarz, K; Stützer, H | 1 |
| Cho, BY; Choi, CW; Chung, JK; Hong, SW; Lee, DS; Lee, JS; Lee, MC; Lim, SM; So, Y; Youn, YK | 1 |
| Endo, K | 1 |
| Coleman, RE; Culhane, DK; Erasmus, JJ; Goodman, PC; Herndon, JE; Marom, EM; McAdams, HP; Patz, EF | 1 |
| Kotzerke, J; Moog, F; Reske, SN | 1 |
| Brecht-Krauss, D; Delling, G; Guhlmann, A; Hartwig, E; Keppler, P; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Werner, M | 1 |
| Diederichs, C; Elsner, K; Glatting, G; Guhlmann, A; Kotzerke, J; Kreienberg, R; Kühn, T; Messer, P; Neumaier, B; Nüssle, K; Reske, SN; Santjohanser, C; Schirrmeister, H; Träger, H | 1 |
| Conrad, EU; Eary, JF; Folpe, AL; Lyles, RH; Sprouse, JT | 1 |
| O'Doherty, MJ; Smith, MA | 1 |
| Fujii, H; Ide, M; Kubo, A; Mochizuki, Y; Nakahara, T; Shohtsu, A; Takahashi, W; Yasuda, S | 1 |
| Aoki, J; Endo, K; Inoue, T; Mohara, S; Sano, K; Shinozaki, T; Takagishi, K; Tokunaga, M; Watanabe, H; Yanagawa, T | 1 |
| Daldrup-Link, HE; Franzius, C; Jürgens, H; Schober, O; Sciuk, J | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Brecht-Krauss, D; Diederichs, CG; Guhlmann, A; Hartwig, E; Heymer, B; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Von Baer, A | 1 |
| Fazio, F; Landoni, C; Messa, C; Pozzato, C | 1 |
| Brinkschmidt, C; Franzius, C; Jürgens, H; Schober, O; Sciuk, J | 1 |
| Ahmed, AR; Aoki, J; Endo, K; Inoue, T; Oriuchi, N; Shinozaki, T; Takagishi, K; Tokunaga, M; Tomiyoshi, K; Watanabe, H; Yanagawa, T | 1 |
| Akino, H; Kanamaru, H; Okada, K; Oyama, N | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Abdel-Dayem, HM; Ajoedi, ND; Ansari, SM; Dede, F; Heiba, SI; Jana, S | 1 |
| Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Aoki, J; Endo, K; Inoue, T; Ishijima, H; Oya, N; Sato, N; Shinozaki, T; Takagishi, K; Watanabe, H | 1 |
| Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
| Delbeke, D; Grigolon, MV | 1 |
| Daldrup-Link, HE; Franzius, C; Jürgens, H; Laukamp, D; Link, TM; Rummeny, EJ; Schober, O; Sciuk, J | 1 |
| Bernd, L; Burger, C; Dimitrakopoulou-Strauss, A; Ewerbeck, V; Heichel, TO; Lehner, B; Strauss, LG; Wu, H | 1 |
| Aoki, J; Endo, K; Ichikawa, A; Inoue, T; Koyama, K; Matsubara, K; Oriuchi, N; Sato, N; Suzuki, H; Tomiyoshi, K | 1 |
| Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeung, HW | 1 |
| Kubota, M; Makuuchi, H; Nasu, S; Ohta, M; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Aoki, J; Endo, K; Inoue, T; Shinozaki, T; Takagishi, K; Tomiyoshi, K; Watanabe, H | 1 |
| Hung, GU; Kao, CH; Tan, TS; Wang, SJ | 1 |
| Bockisch, A; Franzius, C; Hillmann, A; Jürgens, H; Schober, O; Schulte, M; Winkelmann, W | 1 |
| Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Pötzi, C; Schmaljohann, J; Staudenherz, A; Vierhapper, H | 1 |
| Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW | 1 |
| Healey, J; Macapinlac, H; Núñez, R; Sánchez Salmón, A; Yeung, H | 1 |
| Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
| Bernd, L; Burger, C; Dimitrakopoulou-Strauss, A; Ewerbeck, V; Heichel, T; Strauss, LG; Wu, H | 1 |
| Cabrera Villegas, A; Ciria Santos, JP; Martín Urreta, JC | 1 |
| Akhurst, T; Larson, SM; Macapinlac, H; Morris, MJ; Nunez, R; Osman, I; Scher, HI; Schwartz, L; Siedlecki, K; Verbel, D | 1 |
| Arsos, G; Karakatsanis, C; Karatzas, N; Koukoulidis, A; Venizelos, I | 1 |
| Dresel, S; Hahn, K; Rink, FJ; Rock, C; Schmid, RA; Schwenzer, K; Weiss, M | 1 |
| Kao, CH; Lee, CC; Liang, JA; Lin, CC; Lin, FJ; Yang, SN | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
| Adler, LP; al-Kaisi, N; Blair, HF; Joyce, MJ; Leisure, G; Makley, JT; Miraldi, F; Williams, RP | 1 |
| Aho, A; Ahonen, A; Ekfors, T; Paul, R; Virtama, P | 1 |
| Minn, H; Soini, I | 1 |
118 review(s) available for fluorodeoxyglucose f18 and Bone Cancer
| Article | Year |
|---|---|
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Young Adult | 2022 |
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Whole Body Imaging | 2022 |
Whole body imaging in musculoskeletal oncology: when, why, and how.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2023 |
Molecular imaging of sarcomas with FDG PET.
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2023 |
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma.
Topics: Bone Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma | 2023 |
Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.
Topics: Adult; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Mastectomy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response.
Topics: Bone Neoplasms; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Liver Neoplasms; Male; Monitoring, Physiologic; Neoplasms; Patient Care Planning; Positron-Emission Tomography; Quality Improvement; Radiation Oncology; Radiology, Interventional | 2019 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2020 |
Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroectodermal Tumors, Primitive; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2020 |
The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2021 |
Systemic treatment of a metastatic carotid body tumor: A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vincristine | 2020 |
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing | 2021 |
Primary pulmonary artery sarcoma with intrapulmonary metastases based on PET/CT imaging: a case report and literature review.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma | 2021 |
Practice and prospects for PET/CT guided interventions.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymphoma; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2021 |
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2021 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2017 |
Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2018 |
PET/CT in the diagnosis and prognosis of osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2018 |
Nuclear Medicine Imaging in the Dentomaxillofacial Region.
Topics: Acquired Hyperostosis Syndrome; Bone Neoplasms; Face; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Infections; Mandibular Condyle; Maxilla; Osteitis Deformans; Periodontitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sjogren's Syndrome; Technetium Tc 99m Medronate; Technology, Dental; Temporomandibular Joint Disorders; Tomography, X-Ray Computed | 2018 |
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium | 2018 |
Musculoskeletal Pitfalls on Fluorodeoxyglucose F 18 PET-Computed Tomography: Pictorial Review.
Topics: Bone Neoplasms; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Musculoskeletal Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
PET in the Diagnostic Management of Soft Tissue Sarcomas of Musculoskeletal Origin.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Neoplasm Staging; Neoplasms, Connective and Soft Tissue; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Treatment Outcome | 2018 |
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
Topics: Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult | 2018 |
Metastatic Seeding Attacks Bone Marrow, Not Bone: Rectifying Ongoing Misconceptions.
Topics: Bone Marrow; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma, Ewing; Sensitivity and Specificity; Young Adult | 2018 |
Solitary Plasmacytoma: a Review of Diagnosis and Management.
Topics: Bone Neoplasms; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Myeloma Proteins; Plasma Cells; Plasmacytoma; Positron Emission Tomography Computed Tomography | 2019 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon | 2013 |
Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
Imaging appearance of sarcomas of the prostate.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Role of positron emission tomography/computed tomography in bone malignancies.
Topics: Biopsy; Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Desmoplastic fibroma of the scapula with fluorodeoxyglucose uptake on positron emission tomography: a case report and literature review.
Topics: Aged; Bone Neoplasms; Female; Fibroma, Desmoplastic; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Scapula | 2013 |
[State of the art in nuclear imaging for the diagnosis of bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms | 2013 |
18 FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis.
Topics: Bone Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[Why is PET/CT essential in urooncology?].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms | 2013 |
Intraosseous hibernoma: characterization of five cases and literature review.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lipoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
FDG PET/CT of primary bone tumors.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2014 |
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.
Topics: Bone Marrow; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; RANK Ligand | 2015 |
Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Assessing the role of ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasms, Muscle Tissue; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Topics: Bone Neoplasms; Chi-Square Distribution; Fluorodeoxyglucose F18; Humans; Odds Ratio; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 2016 |
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Multi-technique imaging of bone metastases: spotlight on PET-CT.
Topics: Bone Neoplasms; Choline; Contrast Media; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2016 |
Advances in diagnosis and treatment of metastatic cervical cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Topics: Bone Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tumor Burden | 2016 |
Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2017 |
Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Sarcoma | 2008 |
Utilization of positron emission tomography in the management of patients with sarcoma.
Topics: Bone Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2009 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Imaging metastatic bone disease from carcinoma of the prostate.
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors.
Topics: Bone and Bones; Bone Diseases, Metabolic; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging | 2010 |
[Nuclear medicine diagnosis of bone metastases].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy.
Topics: Adolescent; Bone and Bones; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Osteosarcoma; Radionuclide Imaging; Tomography, X-Ray Computed | 2009 |
A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radionuclide Imaging | 2011 |
PET/CT in primary musculoskeletal tumours: a step forward.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Forecasting; Humans; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT in pediatric solid tumors.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Fluorodeoxyglucose F18; Hepatoblastoma; Histiocytosis, Langerhans-Cell; Humans; Liver Neoplasms; Neoplasms; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.
Topics: Absorptiometry, Photon; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2011 |
[Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoma | 2011 |
Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Irradiation | 2012 |
Hematopoietic tumors and metastases involving bone.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Lymphoma; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2012 |
Bony metastases: assessing response to therapy with whole-body diffusion MRI.
Topics: Bone Marrow; Bone Neoplasms; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Whole Body Imaging | 2011 |
Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG.
Topics: Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2011 |
18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2012 |
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?
Topics: Aged; Bone Marrow; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Meta-Analysis as Topic; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Assessment of therapy response by FDG PET in pediatric patients.
Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Lymphoma; Male; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed; Treatment Outcome | 2003 |
FDG-PET for evaluating musculoskeletal tumors: a review.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
PET imaging of osteosarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Fused functional-anatomic images of metastatic cancer of cervix obtained by a combined gamma camera and an X-ray tube hybrid system with an illustrative case and review of the 18F-fluorodeoxyglucose literature.
Topics: Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Diagnosis of occult bone metastases: positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
The role of nuclear medicine in the diagnosis of cancer of unknown origin.
Topics: Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasms, Unknown Primary; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Musculoskeletal system.
Topics: Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Soft Tissue Neoplasms | 2004 |
Positron emission tomography and bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid | 2005 |
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
The contribution of PET/CT to improved patient management.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2006 |
Staging in oesophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Role for positron emission tomography in skeletal diseases.
Topics: Arthritis; Bone Diseases; Bone Diseases, Infectious; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases; Sensitivity and Specificity; Vasculitis | 2007 |
A case of SAPHO (synovitis-acne-pustulosis-hyperostosis-osteomyelitis) syndrome in which [18F]fluorodeoxyglucose positron emission tomography was useful for differentiating from multiple metastatic bone tumors.
Topics: Acquired Hyperostosis Syndrome; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Osteolysis; Osteosclerosis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2007 |
[Clinical usefulness of positron emission tomography in prostate cancer].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2007 |
Detection of bone metastases in breast cancer by positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
[Interests and perspectives of PET-CT for breast cancer: review of the literature].
Topics: Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
PET and PET/CT with F-18 fluoride in bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The roles of PET and PET/CT in the diagnosis and management of prostate cancer.
Topics: Bone Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Neoplasms; Radioimmunodetection; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.
Topics: Area Under Curve; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2007 |
PET/CT in malignant bone disease.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Case report: Solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypophosphatemia; Indium Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteomalacia; Plasmacytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Thoracic Vertebrae; Tomography, X-Ray Computed | 2008 |
Skeletal metastases from breast cancer: imaging with nuclear medicine.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Radiopharmaceuticals; Technetium Compounds; Tomography, Emission-Computed; Treatment Outcome | 1999 |
[Progress of nuclear oncology].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Radionuclide Imaging; Technetium; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
The role of positron emission tomography in the management of bone metastases.
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 2000 |
The role of positron emission tomography in skeletal disease.
Topics: Bone Diseases; Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography.
Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Nuclear imaging of bone tumors: FDG-PET.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2001 |
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
Topics: Age Factors; Bone Neoplasms; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature.
Topics: Aged; Bone Neoplasms; Chondrosarcoma; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 2002 |
61 trial(s) available for fluorodeoxyglucose f18 and Bone Cancer
| Article | Year |
|---|---|
Intra-individual comparison of
Topics: Bone Neoplasms; Breast Neoplasms; Canada; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon | 2022 |
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Topics: Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Immune Checkpoint Inhibitors; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Prospective Evaluation of Magnetic Resonance Imaging and [
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stem Cell Transplantation; Survival Rate | 2017 |
Ewing sarcoma during follow-up.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2017 |
Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reading; Retrospective Studies; Whole Body Imaging | 2019 |
Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2013 |
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Prostatic Neoplasms; Registries; Sodium Fluoride; Treatment Outcome | 2015 |
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.
Topics: Aged; Arm; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain; Pain Measurement; Paintings; Positron-Emission Tomography; Radiation Dosage; Radiotherapy Planning, Computer-Assisted | 2015 |
Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peptides, Cyclic; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Infant; Male; Middle Aged; Positron-Emission Tomography; Receptor, IGF Type 1; Sarcoma, Ewing; Time Factors; Treatment Outcome; Young Adult | 2016 |
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2016 |
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2017 |
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Topics: Adolescent; Adult; Bone Neoplasms; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Young Adult | 2017 |
Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2008 |
Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2009 |
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.
Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; Bone Neoplasms; C-Reactive Protein; Cell Proliferation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Male; Multiple Myeloma; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate | 2009 |
[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.
Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Extremities; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Treatment Outcome; Young Adult | 2009 |
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Models, Biological; Osteosarcoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome | 2009 |
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.
Topics: Adolescent; Biological Transport; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Reference Standards; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2010 |
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Survival Analysis; Technetium Tc 99m Medronate | 2010 |
¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.
Topics: Acetates; Bone Neoplasms; Carbon; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2011 |
Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole-Body Irradiation; Young Adult | 2012 |
Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2012 |
¹⁸F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
Topics: Bone Neoplasms; Fluorides; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; International Cooperation; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasms; Nuclear Medicine; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Cervical Vertebrae; Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Lumbar Vertebrae; Male; Pelvis; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Ribs; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Whole-Body Irradiation | 2002 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Topics: Aged; Bone Neoplasms; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chondrosarcoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Washington | 2004 |
Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis.
Topics: Adult; Bacterial Infections; Bone Neoplasms; Chronic Disease; Diagnosis, Differential; Diagnostic Techniques, Radioisotope; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Comparison of different quantitative approaches to 18F-fluoride PET scans.
Topics: Adolescent; Adult; Aged; Algorithms; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2005 |
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Biomarkers; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoma; Statistics as Topic | 2006 |
FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2007 |
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.
Topics: Aged; Androgens; Bone Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1996 |
Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Observer Variation; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 1998 |
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Necrosis; Neoplasm Staging; Observer Variation; Osteosarcoma; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
Topics: Adolescent; Adult; Aged; Algorithms; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Reference Standards; Tomography, Emission-Computed | 2001 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Medronate | 2002 |
679 other study(ies) available for fluorodeoxyglucose f18 and Bone Cancer
| Article | Year |
|---|---|
Angiosarcoma presenting as unexplainable unilateral leg pain and purpuric toes.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Intestinal Neoplasms; Intestine, Small; Leg; Male; Muscle Neoplasms; Pain; Positron Emission Tomography Computed Tomography; Purpura; Radiopharmaceuticals; Toes | 2021 |
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
FDG PET/CT of Primary Ewing Sarcoma of the Peritoneum.
Topics: Adolescent; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneum; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing | 2022 |
What is the clinical impact of staging and surveillance PET-CT scan findings in patients with bone and soft tissue sarcoma?
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2022 |
Osteoblastoma of the Rib Mimicking Lymphomatous Involvement on 18F-FDG PET/CT Imaging.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Neoplasm Staging; Osteoblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2022 |
18F-FDG PET/CT in Clear Cell Sarcoma With Multiple Bone Metastases.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Clear Cell | 2022 |
Chondrosarcoma of the spine-a case report.
Topics: Aged; Bone Neoplasms; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Quality of Life; Retrospective Studies; Thyroid Neoplasms | 2022 |
PET-CT staging affects time to treatment in sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Time-to-Treatment | 2022 |
Intense 68Ga-FAPI Uptake in a Patient With Myositis Ossificans: Mimicking Bone Malignancy.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Myositis Ossificans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
FDG PET/CT and Bone Scintigraphy in Desmoplastic Fibroma of the Bone.
Topics: Bone Neoplasms; Fibroma, Desmoplastic; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Technetium Tc 99m Medronate | 2022 |
Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder.
Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2022 |
Hematopoietic islands mimicking osteoblastic metastases within the axial skeleton.
Topics: Aged; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
68 Ga-FAPI-04 PET/CT in Epithelioid Hemangioendothelioma With Pleura and Bone Metastases.
Topics: Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Pleura; Positron Emission Tomography Computed Tomography; Quinolines; Sarcoma | 2022 |
Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy.
Topics: Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quality of Life; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Adamantinoma-Like Ewing Sarcoma of the Mandible Evaluated on 18F-FDG PET/CT.
Topics: Adamantinoma; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Male; Mandible; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing | 2022 |
Epiglottic Polymorphous Adenocarcinoma With Multiple Bone Metastases Detected by 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
An uncommon and aggressive presentation of ceruminous adenocarcinoma of external auditory canal detected with
Topics: Adenocarcinoma; Bone Neoplasms; Ear Canal; Ear Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2022 |
Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Influence of inputs for bone lesion segmentation in longitudinal
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.
Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2022 |
Percutaneous Biopsy of Metastatic Bone Lesions Invisible on Conventional Computed Tomography.
Topics: Biopsy; Bone Neoplasms; Cartilage Diseases; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging | 2022 |
18F-FDG PET/CT of Primary Extraskeletal Ewing Sarcoma of the Prostate.
Topics: Adolescent; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Sarcoma, Ewing | 2022 |
Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed: Outcomes in the 3D Era.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Plasmacytoma; Radiotherapy, Conformal; Retrospective Studies; Treatment Outcome | 2022 |
A suspected case of intertrabecular systemic bone metastasis of small-cell lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2023 |
Detection of Bone Metastases by
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Neuroendocrine Tumors; Osteolysis; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; Retrospective Studies | 2022 |
In vivo
Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Osteogenesis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sarcoma, Ewing | 2023 |
Hypermetabolic Subserosal Uterine Leiomyoma With Synchronous Atypical Multiple Myeloma Mimicking Ovarian Malignancy With Multiple Bone Metastases on 18F-FDG PET/CT.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Multiple Myeloma; Myoma; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Neoplasms | 2023 |
18 F-FDG PET/CT of a Rare Sternal Osteoblastoma in a Man With History of Lymphoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Osteoblastoma; Positron Emission Tomography Computed Tomography; Sternum | 2023 |
68 Ga-FAPI-04 PET/CT In Primary Signet Ring-Like Cell Carcinoma of Prostate With Bone Metastases.
Topics: Aged; Bone Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Cirrhosis; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate | 2023 |
99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2023 |
Assessment of bone lesions with 18 F-FDG PET/MRI in patients with nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroblastoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Reference Standards; Sensitivity and Specificity; Whole Body Imaging | 2023 |
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Sternum; Thrombosis | 2023 |
Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2023 |
Generalized Muscular Uptake of 99m Tc-MDP on Bone Scan in a Patient With Scleromyxedema-Associated Myopathy.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscular Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Scleromyxedema; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2023 |
Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model.
Topics: Animals; Biomarkers; Bone Neoplasms; Child; Disease Models, Animal; Fluorodeoxyglucose F18; Heterografts; Humans; Metformin; Mice; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2023 |
18 F-FDG PET/CT Imaging Findings of a Case of Primary Cardiac Chondrosarcoma and Pulmonary Inflammation.
Topics: Adult; Bone Neoplasms; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Pneumonia; Positron Emission Tomography Computed Tomography | 2023 |
Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Stomach | 2023 |
Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
Topics: Bone Neoplasms; Child, Preschool; DEAD-box RNA Helicases; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Registries; Retrospective Studies; Ribonuclease III; Sensitivity and Specificity | 2023 |
Isolated Skull Metastasis With Unusual Spiculated Periosteal Reaction From Rectal Cancer Resembling Osteosarcoma on FDG PET/CT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Skull | 2023 |
Syphilis Mimicking Malignant Pulmonary Tumor With Nodal and Bone Metastasis on 18 F-FDG PET/CT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syphilis | 2023 |
Lytic Bony Lesions On 18 F-FDG PET-CT Versus 99m Tc MDP Bone Scan.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hemangioendothelioma, Epithelioid; Humans; Treatment Outcome; Young Adult | 2019 |
Askin's tumor in an elderly patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Clinical Deterioration; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymph Nodes; Male; Mediastinum; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Thoracic Wall | 2019 |
68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma.
Topics: Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing; Young Adult | 2020 |
Multiple myeloma mimicking primary bone tumour.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bortezomib; Cyclophosphamide; Dexamethasone; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Neoplasms, Multiple Primary; Osteolysis; Plasma Cells; Positron-Emission Tomography | 2019 |
[The chemotherapy response evaluated by (99m)Tc-HTOC, (18)F-FDG PET-CT and whole body bone scan for a case of childen with neuroblastoma].
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2019 |
Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Patient Positioning; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography | 2019 |
Optimized CT Attenuation and SUV Prediction Thresholds for Differentiating Enostoses From Untreated and Treated Metastases on Attenuation-Corrected 18F-FDG PET/CT.
Topics: Aged; Biological Transport; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Osteoblasts; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2020 |
Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Solitary Bone Langerhans Cell Histiocytosis Demonstrated on Multimodality Imaging in an Adult.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
MRI versus
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2020 |
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Topics: Adult; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neoplasm Staging; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2019 |
Distribution of Femoral Metastases; Potential Role for Extended FDG PET/CT Scanning.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Femur; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2020 |
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
Case Report 18F-FDG PET/CT of Pseudomyogenic Hemangioendothelioma.
Topics: Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
Topics: Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Omentum; Palliative Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival; Tomography, X-Ray Computed | 2020 |
Rib Plasmacytoma With Unusual Sunburst Periosteal Reaction.
Topics: Adult; Biopsy; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Osteogenesis; Plasmacytoma; Positron Emission Tomography Computed Tomography; Ribs | 2020 |
The concomitance of lymphoma and breast carcinoma in the bone.
Topics: Biomarkers, Tumor; Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
Vanishing Bone Metastases in 18F-FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Thoracic Vertebrae | 2020 |
Primary bone lymphoma of the thoracic vertebra in a patient with metastatic lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2020 |
Popliteal lymph nodes in patients with osteosarcoma: are they metastatic?
Topics: Adolescent; Adult; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Young Adult | 2020 |
Adrenal and Bone Metastases as the Initial Presentation of Endometrial Carcinoma Diagnosed by 18F-FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2020 |
Multimodality Imaging Features of a Misleading Sacral Giant Cell Tumor in 18F-FDG PET/CT, Bone Scan, and MRI.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Sacrum | 2020 |
Different
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Male; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sarcoma, Ewing; Survival Rate | 2020 |
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Topics: Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Tumor Burden | 2020 |
Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Topics: Aged; Bone and Bones; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Risk | 2020 |
Assessment of Bone Lesions with
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Technetium | 2021 |
Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma.
Topics: Aged; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Sarcoma; Solitary Fibrous Tumors; Tunica Intima; Vascular Neoplasms | 2020 |
68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
Utility of Bone Scintigraphy and PET-CT in the Surgical Staging of Skeletal Chondrosarcoma.
Topics: Bone and Bones; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, X-Ray Computed | 2020 |
Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
Topics: Aged; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Osteosarcoma; Positron Emission Tomography Computed Tomography; Sternum | 2021 |
Calcified Adrenal Metastasis of High-Grade Osteosarcoma on FDG PET/CT.
Topics: Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Calcinosis; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Grading; Osteosarcoma; Positron Emission Tomography Computed Tomography | 2021 |
In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
Topics: Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Rats; Rats, Nude; Serial Passage; Triple Negative Breast Neoplasms | 2020 |
18F-FDG PET/CT Imaging of Pancreatic and Adrenal Metastases in a Patient With Mesenchymal Chondrosarcoma.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Chondrosarcoma, Mesenchymal; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult | 2021 |
The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients
Topics: Bone Neoplasms; Child; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Retrobulbar metastasis of breast primary- Once in a blue moon lesion.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Isolated Unilateral Orbital Metastasis From Ewing Sarcoma Detected on FDG PET/CT Scan.
Topics: Bone Neoplasms; Child; Femur; Fluorodeoxyglucose F18; Humans; Male; Orbital Neoplasms; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing; Whole Body Imaging | 2021 |
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging; Young Adult | 2021 |
Perceptual omission errors in positron emission tomography and computed tomography reporting.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
Topics: Bone Neoplasms; Child; Child, Preschool; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Male; Multivariate Analysis; Neuroblastoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prognosis; Progression-Free Survival; Retrospective Studies; Risk Assessment; Risk Factors; Tumor Burden | 2021 |
[Use of PET/CT for staging of Ewing's sarcoma. Report of one case].
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Carcinosarcoma Gallbladder With Osteosarcomatous Differentiation.
Topics: Bone Neoplasms; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Gallbladder; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Atypical presentation of colorectal carcinoma with sole multiple osteolytic bone metastases: a case report.
Topics: Adenocarcinoma; Bone Neoplasms; Colorectal Neoplasms; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged | 2021 |
FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taiwan | 2021 |
Recurrent Subcutaneous Ewing Sarcoma on 18F-FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma, Ewing; Young Adult | 2021 |
Osteolytic-variant POEMS syndrome: an uncommon presentation of "osteosclerotic" myeloma.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
Topics: Aged; Bone Neoplasms; Diphosphonates; Fluorodeoxyglucose F18; Gingivitis; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Maxilla; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Skin Neoplasms; Testicular Neoplasms; Tooth Extraction; Treatment Outcome; Whole Body Imaging | 2017 |
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tumor Burden | 2017 |
[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sodium Fluoride; Young Adult | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Topics: Adult; Astrocytoma; Bone Neoplasms; Brain Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2017 |
Thymic carcinoma initially presented with geographic destruction of scapula in a child.
Topics: Biopsy; Bone Neoplasms; Child; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Scapula; Thymus Neoplasms | 2017 |
Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Biological; Models, Statistical; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
[Bone metastases of a gallbladder carcinoma detected by positron emission tomography/computed tomography: Case report].
Topics: Aged; Bone Neoplasms; Carcinoma, Signet Ring Cell; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
The value of 18F-FDG PET/CT imaging in breast cancer staging.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Young Adult | 2018 |
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula | 2017 |
18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plasmacytoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Young Adult | 2017 |
Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging.
Topics: Adult; Aged; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2017 |
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.
Topics: Adolescent; Amputation, Surgical; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Limb Salvage; Male; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
A Case of Anaplastic Oligodendroglioma With Extensive Extraneural Metastases Imaged With FDG PET.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Positron-Emission Tomography | 2017 |
On the
Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Positron-Emission Tomography; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed | 2018 |
Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2018 |
Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
Topics: Adolescent; Adult; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Ilium; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing | 2018 |
Pseudolesions Impersonating Osseous Tumor Involvement on Both Contrast Enhanced CT and FDG PET/CT.
Topics: Aged; Bone Neoplasms; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Spine | 2018 |
Dilated Internal Thoracic Vertebral Venous Plexus Simulating Bone Metastases on FDG PET/CT.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Superior Vena Cava Syndrome; Thoracic Vertebrae; Thymoma | 2018 |
FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Image-Guided Biopsy; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis | 2018 |
18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Young Adult | 2018 |
Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Radiomics Features Differentiate Between Normal and Tumoral High-Fdg Uptake.
Topics: Adolescent; Adult; Algorithms; Bone and Bones; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tumor Burden; Young Adult | 2018 |
Active Bone Marrow With Focal FDG Accumulation Mimicking Bone Metastasis With a Case of Early Esophageal Cancer.
Topics: Aged; Biological Transport; Bone Marrow; Bone Neoplasms; Esophageal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Time Factors | 2018 |
Superiority of 18F-NaF PET/CT for the detection of bone metastases.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Tumor Burden | 2018 |
In Vitro and In Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma.
Topics: Adaptation, Physiological; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Mice; Neoplasm Invasiveness; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiation Dose Hypofractionation; Radiation Tolerance; Radiopharmaceuticals; Sarcoma, Ewing; TOR Serine-Threonine Kinases | 2018 |
Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Sarcoma, Ewing | 2018 |
Topics: Adolescent; Bone Marrow Neoplasms; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2018 |
Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Humeral Head; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron Emission Tomography Computed Tomography; Remission Induction; Treatment Outcome | 2018 |
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Technetium Tc 99m Medronate | 2018 |
Increased FDG Uptake in a Giant Bone Island Mimicking Malignancy.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Isolated solitary recurrent skull metastasis in papillary thyroid carcinoma.
Topics: Adult; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Skull; Thyroglobulin; Thyroid Neoplasms | 2018 |
Prospective Study of Serial
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2018 |
Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: A case report.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Hospitalization; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spleen; Splenic Neoplasms; Tomography, X-Ray Computed | 2018 |
Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Efficacy and Limitations of F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography to Differentiate Between Malignant and Benign Bone and Soft Tissue Tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Young Adult | 2018 |
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Middle Aged; Osteoblasts; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2018 |
99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Multiple Extraskeletal Osteosarcomas.
Topics: Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate | 2018 |
Earlier Phases of Bone Scintigraphy Can Better Delineate the Extent of Soft Tissue Involvement of Bone Metastasis.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Technetium Tc 99m Medronate | 2018 |
Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
Topics: Adolescent; Adult; Area Under Curve; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome; Young Adult | 2018 |
PET/CT Imaging for Solitary Primary Bone Lymphoma of Thoracic Vertebra.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2018 |
What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Topics: Adult; Aged; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast; Breast Neoplasms; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Whole Body Imaging | 2018 |
Multiple Intravascular Papillary Endothelial Hyperplasia of Bone Mimicking Malignancy on 99mTc-MDP Bone Scan and 18F-FDG PET/CT.
Topics: Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Endothelial Cells; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Middle Aged; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate | 2019 |
Prognostic significance of maximum standardized uptake value on 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Robotics | 2019 |
Percutaneous Cementoplasty For Acetabulum In Patients With Bone Metastasis.
Topics: Acetabulum; Adult; Aged; Aged, 80 and over; Bone Cements; Bone Neoplasms; Cancer Pain; Cementoplasty; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymethyl Methacrylate; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2017 |
Unusual Focal Muscle FDG Activity Related to Altered Biomechanics.
Topics: Biological Transport; Biomechanical Phenomena; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mechanical Phenomena; Muscles; Osteosarcoma; Positron Emission Tomography Computed Tomography; Young Adult | 2019 |
Primary Common Iliac Artery Angiosarcoma With Multiple Bone Metastases Revealed by Dual-Time Point FDG PET/CT Imaging.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Iliac Artery; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Diffuse Skeletal Hemangiomatosis Mimicking Metastastic Disease on 18F-FDG PET/CT.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hemangioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2019 |
Gummatous Syphilis Mimicking Malignant Bone Tumor on FDG PET/CT.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Syphilis | 2019 |
Can pretreatment
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; China; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Whole Body Imaging; Young Adult | 2019 |
Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cancer Pain; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2019 |
The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Molecular Imaging; Morpholines; Osteoclasts; Positron Emission Tomography Computed Tomography; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome; X-Ray Microtomography | 2019 |
Challenges in the treatment of parathyroid carcinoma: a case report.
Topics: Adult; Bone Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Jaw Diseases; Neoplasms, Multiple Primary; Osteolysis; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2019 |
Bone Pseudometastasis on 18F-FDG PET in Japanese Patients With Esophageal Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sweden; Treatment Outcome; Young Adult | 2019 |
Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Young Adult | 2020 |
A Stepwise Approach to Identify the Clinical Role of 18F-FDG PET/CT in Patients With Suspicious Bone Metastasis From an Unknown Primary Site.
Topics: Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography | 2019 |
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Topics: Antineoplastic Protocols; Bone Neoplasms; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
Topics: Automation; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Retrospective Studies; Whole Body Imaging | 2019 |
Assessment of atherosclerosis in oncologic patients using ¹⁸F-fluoride PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disseminated Intravascular Coagulation; Docetaxel; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Failure | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Primary synovial sarcoma of the kidney with unusual follow up findings.
Topics: Adolescent; Biopsy; Bone Diseases, Developmental; Bone Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy; Femur; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Nephrectomy; Positron-Emission Tomography; Sarcoma, Synovial; Translocation, Genetic; Treatment Outcome | 2013 |
(18)F-FDG PET/CT imaging of metastatic atypical fibroxanthoma.
Topics: Adult; Ankle; Biopsy; Bone Neoplasms; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Radiography; Radionuclide Imaging; Xanthomatosis | 2013 |
Cholesterol granuloma: a rare benign rib tumor.
Topics: Adult; Bone Neoplasms; Cholesterol; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Ribs | 2013 |
Solitary bony metastasis in seminoma.
Topics: Biomarkers, Tumor; Bone Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Contrast Media; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Orchiectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Rotator Cuff; Seminoma; Shoulder Impingement Syndrome; Testicular Neoplasms; Tomography, X-Ray Computed | 2013 |
Granulosa cell tumor of the ovary with high FDG uptake.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Ovariectomy; Positron-Emission Tomography | 2013 |
Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.
Topics: Bone Neoplasms; Drug Combinations; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
SDHB gene positive metastatic paraganglioma associated with lesions which demonstrate both positive and negative uptake of 18FDG PET and 131MIBG.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Fluorodeoxyglucose F18; Genotype; Humans; Ireland; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase | 2013 |
Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2013 |
18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Topics: Adolescent; alpha-Fetoproteins; Biomarkers, Tumor; Bone Neoplasms; Endodermal Sinus Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Mice; Misonidazole; Osteoblasts; Osteoclasts; Osteosarcoma; Phenotype; Positron-Emission Tomography; Tibia | 2013 |
Real-time FDG PET/CT-guided bone biopsy in a patient with two primary malignancies.
Topics: Aged, 80 and over; Bone Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer.
Topics: Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Observations on the effects of lithium on carcinoid tumors.
Topics: Bone Neoplasms; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lithium Compounds; Liver Neoplasms; Male; Mood Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Asymmetric (99m)Tc-MDP uptake in mineralized tendons might mimic bone lesions: heterotopic tendon mineralization on a (99m)Tc-MDP bone scan and a (18)F-FDG PET/CT scan.
Topics: Bone Neoplasms; Calcinosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tendons; Tomography, X-Ray Computed | 2014 |
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |
Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Strontium Radioisotopes; Tomography, X-Ray Computed | 2014 |
FDG PET uptake as a predictor of pain response in palliative radiation therapy in patients with bone metastasis.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pain Measurement; Pain, Intractable; Palliative Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Methyltyrosines; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies.
Topics: Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Clinical outcome prediction of percutaneous cementoplasty for metastatic bone tumor using (18)F-FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cementoplasty; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pain; Positron-Emission Tomography; Postoperative Complications; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Surgical resection of a solitary plasmacytoma originating in a rib.
Topics: Aged; Biopsy; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Multimodal Imaging; Osteotomy; Plasmacytoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracotomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parathyroid Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Bone Neoplasms; Diagnosis, Differential; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Osteoblastoma is a metabolically active benign bone tumor on 18F-FDG PET imaging.
Topics: Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Osteoblastoma; Positron-Emission Tomography | 2013 |
Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
Topics: Adenocarcinoma, Follicular; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
TB determined: tuberculous osteomyelitis.
Topics: Antitubercular Agents; Aza Compounds; Bone Neoplasms; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fluorodeoxyglucose F18; Fluoroquinolones; Humans; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Moxifloxacin; Osteomyelitis; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Rifampin; Spine; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2014 |
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Incarcerated umbilical hernia of unexpected origin: a primitive neuroectodermal tumor with early recurrence.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hernia, Umbilical; Herniorrhaphy; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reoperation; Sarcoma, Ewing; Time Factors; Treatment Outcome | 2014 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Luminescent Measurements; Magnetic Resonance Imaging; Male; Mice; Osteolysis; Osteosarcoma; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed | 2014 |
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Topics: Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Facial Bones; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skull; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2014 |
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2014 |
Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Leg; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Vascular Neoplasms | 2014 |
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
(18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Ganglioneuroblastoma; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Treatment Outcome | 2014 |
18F-FDG PET/CT in a case of multifocal skeletal tuberculosis without pulmonary disease and potential role for monitoring treatment response.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2014 |
18F-FDG PET/CT superscan in prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Time Factors | 2014 |
Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Young Adult | 2014 |
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
Topics: Adolescent; Adult; Bone Density Conservation Agents; Bone Neoplasms; Child; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed | 2014 |
Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Topics: Aged; Biomarkers, Tumor; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Phantoms, Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, Emission-Computed | 2014 |
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2014 |
Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2014 |
Evaluation of primary bone lymphoma and the importance of positron emission tomography.
Topics: Adolescent; Biopsy; Bone Neoplasms; Chemoradiotherapy; Child; Femoral Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Sensitivity and Specificity | 2014 |
False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Neoplasms; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; False Positive Reactions; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2014 |
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Denosumab; Femoral Neoplasms; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteotomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tibia; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prevalence; Prostatic Neoplasms; Retrospective Studies; Soft Tissue Neoplasms | 2014 |
Sternal intraosseous schwannoma mimicking breast cancer metastasis.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Sternum; Tomography, X-Ray Computed | 2014 |
Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases.
Topics: Bone Neoplasms; Dermatofibrosarcoma; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
Topics: Antimetabolites; Antineoplastic Agents; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Phosphorylation; Protein Processing, Post-Translational; Radiopharmaceuticals; Thymidine Kinase; Tumor Cells, Cultured | 2014 |
Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
Askin tumor: CT and FDG-PET/CT imaging findings and follow-up.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sarcoma, Ewing; Thoracic Neoplasms; Thoracic Surgical Procedures; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET/CT for conventional imaging.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Primary malignant melanoma of the thymus: report of a case.
Topics: Biopsy, Needle; Bone Neoplasms; Brachiocephalic Veins; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Pericardium; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Thymectomy; Thymus Neoplasms; Treatment Outcome | 2015 |
A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice.
Topics: Animals; Body Weight; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Reproducibility of Results; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; X-Ray Microtomography | 2015 |
Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Topics: Area Under Curve; Bone and Bones; Bone Neoplasms; Diagnosis, Computer-Assisted; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms; Support Vector Machine; Tomography, X-Ray Computed | 2014 |
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Pyrrolidines; Sodium Fluoride; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy.
Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Extremities; Female; Fluorodeoxyglucose F18; Humans; Joint Diseases; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
AEG-1 promoter-mediated imaging of prostate cancer.
Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases, Firefly; Male; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Molecular Diagnostic Techniques; Neoplasm Transplantation; Promoter Regions, Genetic; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; RNA-Binding Proteins; Transcriptional Activation | 2014 |
Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid.
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome; Zoledronic Acid | 2015 |
PET/CT and MRI of chondroid lipoma of the deltoid muscle.
Topics: Bone Neoplasms; Chondrosarcoma, Mesenchymal; Deltoid Muscle; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lipoma; Liposarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Asymmetric ischiopubic synchondrosis mimicking skeletal metastasis on positron emission tomography.
Topics: Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ischium; Osteochondrosis; Positron-Emission Tomography; Prognosis; Pubic Symphysis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multiple chest wall swellings in adult Burkitt's lymphoma.
Topics: Bone Neoplasms; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Sternum; Thoracic Wall; Tomography, X-Ray Computed | 2014 |
The acetabular fossa hot spot on 18F-FDG PET/CT: epidemiology, natural history, and proposed etiology.
Topics: Acetabulum; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Incidence; Joint Diseases; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; United States; Young Adult | 2015 |
FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma.
Topics: Bone Neoplasms; Female; Femur; Fibroma; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2015 |
[Intraosseous hibernoma : a possibly not so rare cause of sclerotic bone lesions].
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lipoma; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2014 |
The great mimicker: an extensive bone sarcoidosis.
Topics: Bone and Bones; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
[A case of malignant perivascular epithelioid cell tumor of the retroperitoneum with multiple metastases].
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.
Topics: Aged, 80 and over; Biopsy, Fine-Needle; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tarsal Bones; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
Topics: Adolescent; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Prostheses and Implants; Prosthesis Implantation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Regularized ML reconstruction for time/dose reduction in (18)F-fluoride PET/CT studies.
Topics: Algorithms; Artifacts; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2016 |
Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?
Topics: Basic Helix-Loop-Helix Transcription Factors; Bone Marrow; Bone Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Multiple Myeloma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2015 |
Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Ribs; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2015 |
Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging.
Topics: Bone Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.
Topics: Adolescent; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
FDG PET/CT for bone and soft-tissue biopsy.
Topics: Adult; Bone Neoplasms; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
Topics: Autoradiography; Biopsy; Bone Neoplasms; Calibration; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Logistic Models; Lung Neoplasms; Needles; Positron-Emission Tomography; Probability; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Topics: Adult; Aged; Analgesics, Opioid; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiotherapy; Retrospective Studies; Treatment Outcome | 2015 |
Diffuse Large B-Cell Lymphoma Infiltrating Limb Bones With a Few Lymphadenopathy Revealed on Whole-Body 18F-FDG PET/CT.
Topics: Aged; Axilla; Bone Neoplasms; Fluorodeoxyglucose F18; Groin; Humans; Lower Extremity; Lymph Nodes; Lymphatic Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Upper Extremity | 2015 |
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sensitivity and Specificity; Technetium Compounds | 2016 |
Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
Topics: Adult; Aged; Bone Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteolysis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Density Conservation Agents; Bone Marrow; Bone Neoplasms; Chronic Disease; Dacarbazine; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Osteoblasts; Osteomyelitis; Pain; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sacrum; Tomography, X-Ray Computed; Treatment Failure; Vinblastine | 2015 |
Chloroma--an uncommon cause of arthritis.
Topics: Arthritis; Bone Neoplasms; Elbow Joint; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Myeloid; Tomography, X-Ray Computed | 2015 |
VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT.
Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Zoledronic Acid | 2015 |
[Efficacy of serum immunoglobulin free light chain and 18F-FDG PET/CT for therapeutic evaluation in a case with multiple plasmacytoma of bone].
Topics: Biopsy; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multimodal Imaging; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Marked Hematopoiesis Masquerading Multiple Bone Metastasis in a Lung Cancer Patient With Myelodysplastic Syndrome.
Topics: Bone Marrow; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Myelodysplastic Syndromes; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2015 |
A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Solitary Retroperitoneal Metastasis as the Initial Site of the Relapse of Osteosarcoma Revealed by FDG PET/CT.
Topics: Adolescent; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2015 |
FDG PET/CT Findings of Multifocal Epithelioid Hemangioendotheliomas of the Bones.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radionuclide Imaging | 2016 |
F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.
Topics: Adolescent; Adult; Age Distribution; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Healthcare Disparities; Humans; Male; Medical Records; Neoplasm Grading; Neoplasm Staging; Norway; Positron Emission Tomography Computed Tomography; Practice Patterns, Physicians'; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Time Factors; Young Adult | 2016 |
Giant cell tumor of the clavicle: report of a case in a rare location with consideration of surgical method.
Topics: Biomechanical Phenomena; Biopsy; Bone Neoplasms; Clavicle; Contrast Media; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteotomy; Positron-Emission Tomography; Range of Motion, Articular; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
(18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Luminescent Measurements; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Odds Ratio; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Reproducibility of Results; Research Design; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Tomography, X-Ray Computed | 2015 |
Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Denmark; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2015 |
Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.
Topics: Artifacts; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
Topics: Aged; Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radionuclide Imaging; Research Design; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
FDG PET/CT Manifestation of Rare Widespread Metastatic Chemoradiation-Refractory Thymic Squamous Cell Carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2015 |
Imaging: improving detection of bone metastases in renal cell carcinoma.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Radionuclide Imaging; Research Design; Technetium Tc 99m Medronate | 2015 |
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mammography; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging; Young Adult | 2015 |
[MRI/PET for the detection of bone metastases. The new gold standard?].
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma with colon involvement.
Topics: Aged; Anaplastic Lymphoma Kinase; Bone Neoplasms; Colonic Neoplasms; Colonoscopy; Fluorodeoxyglucose F18; Humans; Ilium; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Narrow Band Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Remission Induction | 2015 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Utility of F-18 FDG PET/CT on the evaluation of primary bone lymphoma.
Topics: Adult; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
A Rare Cause of Multiple Bone Lesions: Metastasis or Not?
Topics: Alcoholic Neuropathy; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
PET/CT Helps Downgrade an Aggressive-Appearing Rib Mass to a Probable Benign Lesion in a 9-Year-Old Girl.
Topics: Bone Neoplasms; Child; Chondroma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2016 |
Radium-223 dichloride therapy in breast cancer with osseous metastases.
Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Off-Label Use; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Ammonia; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Diagnostic accuracy of imaging methods for the diagnosis of skeletal malignancies: A retrospective analysis against a pathology-proven reference.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Topics: Bone Neoplasms; Breast Neoplasms; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ki-67 Antigen; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2016 |
Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteolysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Young Adult | 2016 |
Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.
Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2016 |
Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain Management; Palliative Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Regression Analysis; Spinal Neoplasms; Time Factors; Tomography, X-Ray Computed | 2016 |
Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2016 |
Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Retrospective Studies; Young Adult | 2016 |
Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Vincristine | 2015 |
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Male; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Young Adult | 2016 |
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2016 |
Incidental Detection of Subcutaneous Myopericytoma of Trunk on FDG PET/CT and Bone Scintigraphy for Imaging of Colon Cancer.
Topics: Bone Neoplasms; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Torso | 2016 |
Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Topics: Adenocarcinoma; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vulvar Neoplasms | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteoblasts; Osteolysis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
Topics: Bone Neoplasms; Calcium; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Unusual Breast Masses: Ewing Sarcoma Metastases.
Topics: Adolescent; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoma, Ewing; Ultrasonography, Mammary | 2016 |
18F-NaF PET/CT Images of Cardiac Metastasis From Osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm, Residual; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
FDG PET/MRI Imaging of an Angiosarcoma in a Popliteal Aneurysm and Tibial Head After Popliteal Graft.
Topics: Aged; Aneurysm; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Popliteal Artery; Positron-Emission Tomography; Radiopharmaceuticals; Tibia; Vascular Grafting | 2016 |
Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride; Tomography, X-Ray Computed | 2016 |
[Dedifferentiated Chondrosarcoma of the Chest Wall].
Topics: Aged; Bone Neoplasms; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Thoracic Wall; Thoracotomy; Tomography, X-Ray Computed | 2016 |
Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.
Topics: Acetates; Animals; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Mice; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution | 2017 |
Unusual Presentation of Bone Metastasis from Hepatocellular Carcinoma Mimicking as Breast Lump.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed | 2016 |
False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
Topics: Bone Neoplasms; Cell Transformation, Neoplastic; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
Detection of a primary tumor in the area of the renal artery with 18F-FDG PET/CT in a patient with metastatic undifferentiated sarcoma and a history of mid-aortic syndrome: A case report.
Topics: Aortic Diseases; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pelvic Bones; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Renal Artery; Sarcoma; Vascular Neoplasms | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
Primary Left Tibial Epithelioid Hemangioendotheliomas With Multiple Metastases Revealed by FDG PET/CT Imaging.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tibia | 2016 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
A rare case of rectal carcinoma and prostate carcinoma with coexistent Paget's disease mimicking bone metastases in both
Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Oligopeptides; Osteitis Deformans; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rare Diseases; Rectal Neoplasms | 2017 |
Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidism.
Topics: Adenoma; Aged; Biopsy; Bone Neoplasms; Bone Resorption; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.
Topics: Adolescent; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Norway; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult | 2017 |
MRI and 18F-FDG PET/CT of Laryngeal Cartilaginous Tumor.
Topics: Bone Neoplasms; Cartilage; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Skeletal Scintigraphy in Radiation-Induced Fibrosis With Lymphedema.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Lymphedema; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Technetium Tc 99m Medronate | 2017 |
18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; C-Reactive Protein; Child; Female; Fever; Fluorodeoxyglucose F18; Hemoglobins; Humans; L-Lactate Dehydrogenase; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Count; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Young Adult | 2016 |
18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Letrozole; Lymph Node Excision; Lymph Nodes; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Ribs; Taxoids; Triazoles; Zoledronic Acid | 2017 |
Tuberculosis mimicking metastases by malignancy in FDG PET/CT.
Topics: Biopsy; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ribs; Tuberculosis, Osteoarticular | 2017 |
Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
Topics: Bone and Bones; Bone Density; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2017 |
FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Case-Control Studies; Female; Femoral Fractures; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Costal chondrosarcoma requiring differential diagnosis from metastatic tumor.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Bone Neoplasms; Chondrosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteotomy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
MRI and 18F-FDG-PET/CT in a rare case of early (precursor) B-lymphoblastic leukaemia with bone involvement as initial manifestation.
Topics: Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Radiopharmaceuticals | 2017 |
The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Lower-Extremity Pseudomyogenic Hemangioendothelioma on Bone Scintigraphy and PET/CT.
Topics: Adult; Bone Neoplasms; Femur; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2017 |
FDG PET/CT in Pediatric Neurolymphomatosis.
Topics: Animals; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Marek Disease; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2008 |
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Mesothelioma; Neoplasm Metastasis; Neoplasms, Second Primary; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT.
Topics: Adolescent; Bone Neoplasms; Carcinoma, Small Cell; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Practical method for radioactivity distribution analysis in small-animal PET cancer studies.
Topics: Algorithms; Animals; Bone Neoplasms; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tissue Distribution; Whole-Body Counting | 2008 |
Positron emission tomography-CT imaging in guiding musculoskeletal biopsy.
Topics: Adolescent; Adult; Biopsy, Needle; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Musculoskeletal System; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Enhanced FDG uptake in brown tumors mimics multiple skeletal metastases in a patient with primary hyperparathyroidism.
Topics: Adenoma; Biopsy; Bone Neoplasms; Diagnosis, Differential; Fatigue; Fluorodeoxyglucose F18; Granuloma, Giant Cell; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Muscle Weakness; Pain; Parathyroid Neoplasms; Radiographic Image Enhancement; Radiopharmaceuticals; Thyroidectomy | 2008 |
The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; ROC Curve; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2008 |
Primary multifocal osseous lymphoma in a child.
Topics: Arthralgia; Biopsy; Bone Neoplasms; Child; Diagnosis, Differential; Female; Femur; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2008 |
(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation.
Topics: Animals; Bone and Bones; Bone Development; Bone Neoplasms; Cell Differentiation; Cell Division; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Silencing; Genes, myc; Humans; Mice; Mice, Transgenic; Neoplasm Invasiveness; Osteosarcoma; Positron-Emission Tomography; Radiography | 2008 |
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2008 |
Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2009 |
FDG PET/CT findings in secondary hyperparathyroidism not mimicking multiple bone metastases.
Topics: Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Zoledronic Acid | 2009 |
Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.
Topics: Adolescent; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radionuclide Imaging; Retrospective Studies | 2009 |
Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
Topics: Adolescent; Adult; Aged; Biopsy; Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2009 |
Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Osteoblasts; Positron-Emission Tomography; Risk Assessment; Treatment Outcome | 2009 |
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
Topics: Bone Neoplasms; Femur; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Nerve Sheath Neoplasms; Osteitis Fibrosa Cystica; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Radionuclide Imaging; Retrospective Studies; Young Adult | 2010 |
F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease.
Topics: Acquired Hyperostosis Syndrome; Adult; Back Pain; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland.
Topics: Adrenal Gland Neoplasms; Aged; Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sarcoma; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Osteoblastoma and osteoid osteoma: morphofunctional characterization by MRI and dynamic F-18 FDG PET/CT before and after radiofrequency ablation.
Topics: Ablation Techniques; Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Osteoblastoma; Osteoma, Osteoid; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
F-18 flurodeoxyglucose negative, F-18 fluoride accumulating in a brain metastasis in a treated case of carcinoma of the breast.
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Female; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT as a noninvasive diagnostic and follow-up tool in brown tumors due to secondary hyperparathyroidism.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Tumor of Bone; Humans; Hyperparathyroidism, Secondary; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2009 |
The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Follicular thyroid carcinoma with an eggshell calcification: report of 3 cases.
Topics: Adenocarcinoma, Follicular; Aged; Biopsy, Needle; Bone Neoplasms; Calcinosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Ultrasonography, Doppler, Color | 2009 |
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
Topics: Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2009 |
Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2009 |
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Topics: Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; History, 18th Century; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2010 |
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.
Topics: Bone Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Disease Susceptibility; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2010 |
18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Models, Animal; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Statistics as Topic; Treatment Outcome | 2009 |
Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Texas; Tomography, X-Ray Computed | 2010 |
Contemporary imaging in sarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
F-18 FDG PET/CT imaging of cortical bone metastases.
Topics: Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Is there a role for bone scan in Hodgkin lymphoma in the age of 18F-fluorodeoxyglucose positron emission tomography?
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years.
Topics: Aged, 80 and over; Biopsy; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thymus Neoplasms; Time Factors | 2009 |
Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults.
Topics: Adolescent; Bone and Bones; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
Pulmonary artery and femoral vein tumour thromboembolism in a patient with osteogenic sarcoma demonstrated by FDG PET/CT.
Topics: Adult; Bone Neoplasms; Femoral Vein; Fluorodeoxyglucose F18; Humans; Male; Neoplastic Cells, Circulating; Osteosarcoma; Positron-Emission Tomography; Pulmonary Artery; Tomography, X-Ray Computed | 2010 |
Polyostotic fibrous dysplasia mimicking bone metastases in a patient with advanced-stage cervical cancer.
Topics: Adult; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
Topics: Artifacts; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Positron-Emission Tomography | 2010 |
FDG avid patchy bone marrow misinterpreted as melanoma metastases to bone in a case of aplastic anemia.
Topics: Aged; Anemia, Aplastic; Bone Marrow; Bone Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Young Adult | 2010 |
Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT findings of a metastatic pituitary tumor.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Insulin-Like Growth Factor I; Male; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Systems Integration; Tomography, X-Ray Computed | 2010 |
Renal metastasis from Hurthle cell thyroid carcinoma and its evaluation with hybrid imaging.
Topics: Adenocarcinoma, Follicular; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2010 |
Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience.
Topics: Aged; Bone Neoplasms; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain; Pain Measurement; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
Unusual lower limb skeletal metastases from carcinoma of the cervix: detection by F-18 FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leg; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cell Count; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Survival; Tomography, Emission-Computed | 2010 |
Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2011 |
Osteonecrosis in an adolescent with non-Hodgkin lymphoma resembling a new metastatic lesion on (18)F-FDG PET/CT.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2010 |
Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemia; Liver Neoplasms; Male; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Young Adult | 2010 |
PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate | 2011 |
Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion.
Topics: Animals; Bone Morphogenetic Proteins; Bone Neoplasms; Bone Resorption; Cell Line, Tumor; Fluorodeoxyglucose F18; Hindlimb; Humans; Male; Mice; Mice, SCID; Osteoclasts; Osteogenesis; Positron-Emission Tomography; Prostatic Neoplasms; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Fusion Proteins; Signal Transduction; Tibia; Tumor Burden; X-Ray Microtomography | 2011 |
MRI and PET/CT of patients with bone metastases from breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Retroperitoneal extraskeletal osteosarcomas.
Topics: Aged; Bone Neoplasms; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Usefulness of F-18 FDG PET/CT in a case of Kaposi sarcoma with an unexpected bone lesion.
Topics: Bone Neoplasms; CD4 Lymphocyte Count; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2011 |
Bone infarct-associated sarcoma detected on FDG PET/CT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome | 2011 |
PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
Topics: Adolescent; Adult; Aged; Blood Circulation; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Oxygen Radioisotopes; Positron-Emission Tomography; Sarcoma; Treatment Outcome; Water | 2011 |
A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Soft Tissue Neoplasms; Thallium Radioisotopes; Young Adult | 2011 |
Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT.
Topics: Bone Neoplasms; Chondroma; Chondrosarcoma; Diagnosis, Differential; Fibroma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Rhabdomyosarcoma; Tomography, X-Ray Computed; Young Adult | 2011 |
The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2011 |
Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Carbon Radioisotopes; Cell Growth Processes; Child; Choline; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Male; Methyltyrosines; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2011 |
FDG PET/CT differentiating two malignant tumors in the same patient.
Topics: Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Sarcoma, Synovial; Spinal Neoplasms; Tomography, X-Ray Computed | 2012 |
The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Huge tumor thrombus of chondrosarcoma on FDG PET/CT.
Topics: Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Thrombosis; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
[18F-FDG PET/CT in lymphomas: assessment difficulties due to illness characteristics, and comparison with literature data].
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Muscle Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Topics: Adolescent; Biomarkers, Tumor; Bone Neoplasms; Cell Proliferation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Infant; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2011 |
FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Topics: Adult; Biological Transport; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Osteoblastic healing response: discordant PET/CT findings.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteoblasts; Positron-Emission Tomography; Quinazolines; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
Topics: Biopsy; Bone Neoplasms; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Octreotide; Positron-Emission Tomography; Ribs; Sacrum; Spinal Neoplasms; Tomography, X-Ray Computed | 2011 |
Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors.
Topics: Adolescent; Australia; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma.
Topics: Animals; Bone Neoplasms; Bone Remodeling; Cell Growth Processes; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2012 |
Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The appearance of osseous PEComa on F-18 FDG PET/CT.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
(18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Topics: Biopsy; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Diagnostic Errors; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Neoplasm Staging; Palliative Care; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Ribs; Tomography, X-Ray Computed | 2012 |
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Echocardiography; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoma, Ewing; Tomography, X-Ray Computed | 2012 |
PET/CT and MRI of intra-osseous haemangioma of the tibia.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Tibia; Tomography, X-Ray Computed | 2012 |
Earlier detection of bone metastases from pleomorphic liposarcoma in a pediatric patient by FDG PET/CT than planar 99mTc MDP bone scan.
Topics: Bone and Bones; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers.
Topics: Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2012 |
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correction.
Topics: Adult; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphopenia; Middle Aged; Neoplastic Cells, Circulating; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Tomography, Emission-Computed; United States; Women's Health | 2012 |
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Patella; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Primary bone lymphoma involving bilateral tibia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Menisci, Tibial; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Tibia; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Comment on "Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors" (Arch Orthop Trauma Surg. 2010 Jul; 130(7):819-27).
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients.
Topics: Adolescent; Adult; Aged; Biological Transport; Bone Neoplasms; Child; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2012 |
Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
Topics: Bone Marrow; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gelatin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2012 |
Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hexokinase; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2012 |
A case of giant cell tumor of sacrum with unusual pulmonary metastases: CT and FDG PET findings.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Tomography, X-Ray Computed | 2012 |
Skeletal metastases from renal cell carcinoma: diagnostic uncertainty with molecular imaging.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2012 |
[Positron emission tomography-computed tomography in tumors of the locomotor apparatus].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2012 |
Round cell liposarcoma arising in the left foot: MRI and PET findings.
Topics: Aorta, Abdominal; Bone Neoplasms; Fluorodeoxyglucose F18; Foot; Humans; Liposarcoma; Liposarcoma, Myxoid; Lymph Node Excision; Magnetic Resonance Imaging; Male; Metatarsal Bones; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tarsal Bones | 2012 |
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Muscle Tissue; Paclitaxel; Positron-Emission Tomography; Radiography; Thoracic Vertebrae; Treatment Outcome | 2012 |
Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Sarcoidosis; Thorax; Tomography, X-Ray Computed | 2012 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Intramedullary metastasis detected with 18F FDG-PET/CT.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2012 |
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
A prospective study of bone tumor response assessment in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2013 |
Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Technetium Tc 99m Medronate; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
[Diagnostic value of (18)F-labeled NaF positron emission tomography-computed tomography imaging in the detection of bone metastases in patients with lung cancer before treatment].
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Characteristic imaging features of desmoplastic small round cell tumour.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Desmoplastic Small Round Cell Tumor; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2013 |
An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
Topics: Adolescent; Adult; Biopsy, Needle; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2013 |
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Hill-Sachs lesion on FDG PET/CT.
Topics: Bone Neoplasms; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Humeral Head; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Shoulder Dislocation; Tomography, X-Ray Computed | 2013 |
Current role of CT and whole body MRI in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Profiling; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2013 |
[Diagnostic usefulness of FDG-PET/CT in multiple primary osseous Hodgkin lymphoma].
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Ipilimumab in cancer patients: the issue of early metabolic response.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Dermatitis; Fluorodeoxyglucose F18; Humans; Ipilimumab; Lung Neoplasms; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2013 |
Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Tumor localization and biochemical response to cure in tumor-induced osteomalacia.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Calcitriol; Familial Hypophosphatemic Rickets; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Proteins; Octreotide; Osteomalacia; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2013 |
Flare response versus disease progression in patients with non-small cell lung cancer.
Topics: Acute Disease; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Prostate-specific antigen-negative prostate cancer recurrence?
Topics: Aged; Bone Neoplasms; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Nuclear scintigraphy findings for Askin tumor with In111-pentetreotide, Tc99m-MIBI and F18-FDG.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma, Ewing; Somatostatin; Technetium Tc 99m Sestamibi; Thoracic Wall | 2012 |
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Tomography, Emission-Computed | 2002 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Osteosarcoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Medronate; Time Factors; Tomography, Emission-Computed | 2002 |
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.
Topics: Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[F-18 FDG positron emission tomography in diagnosis and follow-up of patients with musculoskeletal tumors].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiotherapy, Adjuvant; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2002 |
Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.
Topics: Adolescent; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Osteosarcoma; Radiopharmaceuticals; Sodium Fluoride; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuroblastoma; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2002 |
Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Role of 18FDG-positron emission tomography scanning in the management of histiocytosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Management; Fluorodeoxyglucose F18; Histiocytosis; Histiocytosis, Langerhans-Cell; Humans; Male; Neoplasm Staging; Tomography, Emission-Computed; Treatment Outcome | 2002 |
F-18 FDG positron emission tomography and benign fractures.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Male; Middle Aged; Radiopharmaceuticals; Rib Fractures; Sensitivity and Specificity; Spinal Fractures; Tomography, Emission-Computed | 2003 |
Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Animals; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Diphosphonates; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Osteomyelitis; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Maryland; Middle Aged; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18FDG PET scanning of benign and malignant musculoskeletal lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Fractures, Bone; Fractures, Spontaneous; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Prognosis of primary osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Osteosarcoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Medronate; Time Factors; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer.
Topics: Abdominal Neoplasms; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pelvic Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Incidental detection of pigmented villonodular synovitis on FDG PET.
Topics: Back; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hip Joint; Humans; Incidental Findings; Melanoma; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Synovitis, Pigmented Villonodular; Tomography, Emission-Computed | 2003 |
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastitis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Sacral fractures: a potential pitfall of FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Prospective Studies; Radiopharmaceuticals; Sacrum; Tomography, Emission-Computed | 2003 |
FDG-PET uptake in occult acute pelvic fracture.
Topics: Bone Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Ilium; Male; Middle Aged; Neoplasm Metastasis; Radiography; Tomography, Emission-Computed | 2004 |
99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
PET scan assessment of chemotherapy response in metastatic paraganglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Unusual presentations of hematologic malignancies: CASE 1. Solitary bone plasmacytoma: role of magnetic resonance imaging and positron emission tomography.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plasmacytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2004 |
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Retroperitoneal Neoplasms; S100 Proteins; Tomography, Emission-Computed | 2004 |
Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2004 |
PET tracers for osteosarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Topics: Bone Neoplasms; Cartilage Diseases; Chondroma; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Osteochondroma; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease.
Topics: Aged; Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals; Scrotum; Sepsis | 2005 |
False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2005 |
FDG-PET in a case of multiple bone metastases of gastric cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone.
Topics: Adult; Aged; Bone Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2005 |
18FDG-PET applications for cartilage neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cartilage Diseases; Child; Chondroma; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Pelvic horseshoe kidney mimics sacral metastases on bone scan.
Topics: Bone Neoplasms; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Kidney; Male; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sacrococcygeal Region; Spinal Neoplasms | 2005 |
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2005 |
Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2005 |
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiographic Image Enhancement; Tomography, Emission-Computed, Single-Photon; Tomography, Spiral Computed | 2005 |
Osteoblastic bone metastases in breast cancer: is not seeing believing?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome | 2005 |
PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer.
Topics: Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lumbar Vertebrae; Middle Aged; Osteoporosis; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Fractures; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Whole body PET/CT for initial staging of choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed | 2005 |
Imaging bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
[18-FDG positon emission tomography and distal metastasis from lung cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Femur; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tibia; Whole Body Imaging | 2005 |
Metastatic lymph node and osteolytic skeletal metastasis detected by FDG-PET in an endoscopy-diagnosed early-stage esophageal cancer.
Topics: Bone Neoplasms; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Osteolysis; Radionuclide Imaging; Radiopharmaceuticals; Sternum | 2005 |
CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chi-Square Distribution; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2005 |
FDG PET and SPECT of bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Surgical Procedures, Operative; Treatment Outcome | 2005 |
False positive 18F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.
Topics: Adult; Biomarkers, Tumor; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Ischium; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2006 |
Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroectodermal Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity | 2006 |
Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Rectal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2005 |
F-18 FDG PET superscan.
Topics: Adenocarcinoma; Adult; Back Pain; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |
False-positive FDG-PET scan due to brown tumours.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Laryngeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Orchiectomy; Peplomycin; Positron-Emission Tomography; Seminoma; Testicular Neoplasms | 2005 |
[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis | 2006 |
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Patient Satisfaction; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
The role of positron emission tomography in pediatric musculoskeletal oncology.
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Obscured bone metastases after administration of hematopoietic factor on FDG-PET.
Topics: Artifacts; Bone and Bones; Bone Neoplasms; Cholangiocarcinoma; Diagnostic Errors; False Negative Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Positron emission tomography (PET)-computed tomography (CT) suggesting small intestinal metastasis from lung cancer; report of a case].
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Ileus; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Lymph Node Excision; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
FDG PET scan in a primitive neuroectodermal tumor.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Skin Neoplasms | 2006 |
The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disease.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Cartilage; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Nephrectomy; Osteogenesis; Osteolysis; Positron-Emission Tomography; Pubic Symphysis; Pubic Symphysis Diastasis; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2006 |
[18F-FDG PET and bone scintigraphy to search for bone metastasis of lung cancer].
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2006 |
Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm.
Topics: Biopsy; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2006 |
[Pet imaging in prostate cancer].
Topics: Acetates; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2006 |
F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases.
Topics: Aged; Bone Neoplasms; Carcinoma, Small Cell; Chromogranins; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Prostate-Specific Antigen; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms | 2006 |
Combined increased and decreased skeletal uptake of F-18 FDG.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Incidental detection of an anterior cruciate ligament injury with FDG PET.
Topics: Anterior Cruciate Ligament; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2006 |
Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prospective Studies | 2006 |
PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease.
Topics: Adolescent; Bone Neoplasms; Child; Female; Femoral Neoplasms; Fibroma; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Tibia; Tomography, X-Ray Computed | 2006 |
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
Topics: Aged; Bone Marrow; Bone Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Benign osteoblastoma of the temporal bone: Case report and review of the literature.
Topics: Aged; Bone Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hearing Loss; Humans; Intraoperative Complications; Neoplasm, Residual; Neuronavigation; Neurosurgical Procedures; Osteoblastoma; Positron-Emission Tomography; Postoperative Hemorrhage; Radiography; Temporal Bone; Tinnitus; Treatment Outcome | 2006 |
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Topics: Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Topics: Adult; Aged; Bone Marrow Transplantation; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Prospective Studies; Whole Body Imaging | 2007 |
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Topics: Bone Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Osteomyelitis; Radiopharmaceuticals; Recurrence; Tibia; Tomography, Emission-Computed | 2007 |
Unsuspected bone and soft tissue lesions identified at cancer screening using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Soft Tissue Neoplasms | 2007 |
18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Technetium Tc 99m Medronate; Whole Body Imaging; Whole-Body Counting | 2008 |
Detection of bone metastases: assessment of integrated FDG PET/CT imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.
Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2007 |
Misdiagnosis of multiple bone metastases due to increased FDG uptake in polyostotic fibrous dysplasia.
Topics: Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Technetium; Tomography, X-Ray Computed | 2007 |
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2007 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Thyroid Neoplasms | 2007 |
F-18 FDG uptake in osteonecrosis mimicking bone metastasis on PET/CT images.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Femur; Fluorodeoxyglucose F18; Humans; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine | 2007 |
Bone and marrow imaging: do we know what we see and do we see what we want to know?
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms | 2007 |
F-18 FDG uptake in the nidus of an osteoid osteoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Osteoma, Osteoid; Positron-Emission Tomography; Radiopharmaceuticals; Tibia | 2007 |
Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management.
Topics: Adult; Bone Neoplasms; Female; Fibroma; Fibromatosis, Abdominal; Fluorodeoxyglucose F18; Gardner Syndrome; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2007 |
Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Topics: Biopsy; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report.
Topics: Bone Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fractures, Spontaneous; Fractures, Stress; Humans; Image Enhancement; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sacrum; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Super scan using positron emission tomography in lung cancer patients.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2007 |
Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Topics: 3-Iodobenzylguanidine; Aged; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thymus Neoplasms | 2007 |
Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases.
Topics: Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Osteosarcoma; Osteotomy; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2007 |
FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Metastatic myxoid liposarcomas: imaging and histopathologic findings.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2007 |
Brown tumors simulating metastases on FDG PET in a patient with parathyroid carcinoma.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Parathyroid Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Immunohistochemistry; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis | 2008 |
Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Soft Tissue Neoplasms | 2008 |
Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Ilium; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Osteoradionecrosis; Positron-Emission Tomography; Radiotherapy, Conformal; Salvage Therapy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Central skeletal sarcoidosis mimicking metastatic disease.
Topics: Biopsy; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed | 2008 |
Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Catecholamines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypertension; Lymphatic Metastasis; Mediastinal Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Increased F-18 FDG accumulation in an acute fracture.
Topics: Adult; Bone Neoplasms; Clavicle; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Processing, Computer-Assisted; Male; Scapula; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1994 |
Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
Topics: Adult; Bone Neoplasms; Deoxyglucose; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Ribs; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1993 |
Reversible Tc-99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. A comparative study using PET FDG whole body imaging.
Topics: Bone Neoplasms; Carcinoma, Bronchogenic; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Stomach; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1996 |
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Muscle Neoplasms; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Topics: Adult; Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Sarcoma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Lung Neoplasms; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Rats; Thymidine; Transcription, Genetic | 1994 |
Fluorine-18-FDG PET in Paget's disease of bone.
Topics: Aged; Bone and Bones; Bone Neoplasms; Deoxyglucose; Diagnosis, Differential; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Osteitis Deformans; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Performance evaluation of a large axial field-of-view PET scanner: SET-2400W.
Topics: Bone Neoplasms; Equipment Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Scattering, Radiation; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1997 |
Detection of unknown occult primary tumors using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed | 1998 |
Bone scanning in clinical oncology: does it have a future?
Topics: Bone and Bones; Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
[Positron emission tomography and bone scintigraphy of an osteoclast metastasis].
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteoblasts; Palliative Care; Radiopharmaceuticals; Ribs; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Topics: Adult; Aged; Autoantibodies; Bone Neoplasms; Carcinoma, Papillary; Data Interpretation, Statistical; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Staging non-small cell lung cancer with whole-body PET.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1999 |
FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Biopsy; Bone and Bones; Bone Marrow; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; ROC Curve; Tomography, Emission-Computed | 1999 |
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 2000 |
Positron emission tomography and the orthopaedic surgeon.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Prognosis; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2000 |
Increased fluorodeoxyglucose uptake in a calf opposite to a leg with osteosarcoma after operation.
Topics: Adult; Bone Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Male; Muscle, Skeletal; Osteosarcoma; Tibia; Tomography, Emission-Computed | 2000 |
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Male; Middle Aged; Musculoskeletal Diseases; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2000 |
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Osteosarcoma; Retrospective Studies; Sarcoma, Ewing; Tomography, Emission-Computed | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Osteosarcoma; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, Emission-Computed | 2000 |
PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 2000 |
[Evaluation of prostate cancer using FDG-PET].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
F-18 FDG uptake in a bone infarct: a case report.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infarction; Middle Aged; Radiopharmaceuticals; Ribs; Tomography, Emission-Computed | 2001 |
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
Multiple skeletal metastases of Ewing's sarcoma demonstrated on FDG-PET and compared with bone and gallium scans.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Sarcoma, Ewing; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2000 |
FDG-PET in adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[FGD PET in a patient with pseudofractures from osteomalacia].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Hyperparathyroidism; Lymphoma; Male; Neoplasms, Unknown Primary; Osteomalacia; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2002 |
The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
Topics: Bayes Theorem; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Metastasis in leptomeninges discovered with PET-FDG].
Topics: Adenocarcinoma; Bone Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Radiosurgery; Rectal Neoplasms; Sigmoid Neoplasms; Spinal Neoplasms; Tomography, Emission-Computed | 2001 |
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2002 |
Monostotic Paget's Disease of a cervical vertebra: differential diagnosis with F-18 FDG positron emission tomography using a coincidence technique and with Tc-99m dicarboxypropane diphosphonate.
Topics: Aged; Bone Neoplasms; Carcinoma; Cervical Vertebrae; Diagnosis, Differential; Diphosphonates; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Osteitis Deformans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Tongue Neoplasms | 2002 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Noninvasive grading of musculoskeletal tumors using PET.
Topics: Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscular Diseases; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1991 |
F-18 fluorodeoxyglucose: its potential in differentiating between stress fracture and neoplasia.
Topics: Adolescent; Bone Neoplasms; Clavicle; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fractures, Stress; Humans; Radionuclide Imaging | 1989 |
[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Radionuclide Imaging | 1989 |